# EDGAR Filing Document

**Accession Number:** 0001679817
**File Stem:** 0001493152-25-024274
**Filing Date:** 2025-11
**Character Count:** 171784
**Document Hash:** fde3c6db2d3c8bd9bf6e0f1acd00531c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-024274.hdr.sgml**: 20251119

**ACCESSION NUMBER**: 0001493152-25-024274

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 78

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251119

**DATE AS OF CHANGE**: 20251119

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** OZOP ENERGY SOLUTIONS, INC.
- **CENTRAL INDEX KEY:** 0001679817
- **STANDARD INDUSTRIAL CLASSIFICATION:** MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 352540672
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-55976
- **FILM NUMBER:** 251499680

**BUSINESS ADDRESS:**
- **STREET 1:** 55 RONALD REAGAN BLVD.
- **CITY:** WARWICK
- **STATE:** NY
- **ZIP:** 10990
- **BUSINESS PHONE:** (845) 544-5112

**MAIL ADDRESS:**
- **STREET 1:** 55 RONALD REAGAN BLVD.
- **CITY:** WARWICK
- **STATE:** NY
- **ZIP:** 10990

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** OZOP SURGICAL CORP.
- **DATE OF NAME CHANGE:** 20180521

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Newmarkt Corp.
- **DATE OF NAME CHANGE:** 20160715

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**Form 10-Q**

☒ Quarterly
 Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

**For the quarter ended September 30, 2025**

☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from __________ to __________

Commission file number **000-55976**

**OZOP ENERGY SOLUTIONS, INC.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| Nevada | 3841 | 35-2540672 |
| (State or Other Jurisdiction of<br> Incorporation or Organization) | (Primary Standard Industrial<br> Classification Number) | (IRS Employer<br> Identification Number) |

---

<u>55 Ronald Reagan Blvd. Warwick, NY 10990 (877) 785-6967</u> <br> (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

Securities registered under Section 12(b) of the Act: **None**

Securities registered pursuant to Section 12(g) of the Act: **Common Stock, $0.001 par value**

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicated by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. :

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use to the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 USC. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

As of November 19, 2025, 12,694,325,835 shares of common stock of the registrant were outstanding.

**OZOP ENERGY SOLUTIONS, INC.**

**CONSOLIDATED FINANCIAL STATEMENTS**

**Table of Contents**

---

| | |
|:---|:---|
|  | **Page** |
| [Consolidated Balance Sheets as of September 30, 2025, and December 31, 2024 (Unaudited)](#H_002) | F-1 |
| [Consolidated Statements of Operations for the three and nine months ended September 30, 2025, and 2024 (Unaudited)](#H_003) | F-2 |
| [Consolidated Statements of Stockholders' Deficit for the three and nine months ended September 30, 2025, and 2024 (Unaudited)](#H_004) | F-3 |
| [Consolidated Statements of Cash Flows for the nine months ended September 30, 2025, and 2024 (Unaudited)](#H_006) | F-5 |
| [Notes to Consolidated Financial Statements (Unaudited)](#H_007) | F-6 |

---

**OZOP ENERGY SOLUTIONS, INC.**

**CONSOLIDATED BALANCE SHEETS**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **September 30,**<br>**2025** | **December 31,**<br>**2024** |
| **ASSETS** |  |  |
| &nbsp;&nbsp;&nbsp;Current Assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash | $341164 | $797139 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses | 17650 | 64851 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | 81787 | 80003 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventory | 129861 | 10673 |
| &nbsp;&nbsp;&nbsp;**Total Current Assets** | 570462 | 952666 |
| Operating lease right-of-use asset, net | 210226 | 226692 |
| Property and equipment, net | 14028 | 561399 |
| Other assets | 13408 | 13408 |
| **TOTAL ASSETS** | $808124 | $1754165 |
| **LIABILITIES AND STOCKHOLDERS' DEFICIT** |  |  |
| &nbsp;&nbsp;&nbsp;Liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current Liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | $11969893 | $10947676 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Related party liabilities | 43000 | 60000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Convertible notes payable, net of discounts | 3169730 | 25000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current portion of notes payable, net of discounts | 18235761 | 20241164 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Derivative liabilities | 1753651 | 210493 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease liability, current portion | 112130 | 163727 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred liability | 525320 | 502610 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Liabilities of discontinued operations | 1034811 | 1034811 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Current Liabilities** | 36844296 | 33185481 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long Term Liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease liability, net of current portion | 106807 | 72662 |
| **TOTAL LIABILITIES** | 36951103 | 33258143 |
| **COMMITMENTS AND CONTINGENCIES** |  |  |
| &nbsp;&nbsp;&nbsp;**Stockholders' Deficit** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preferred stock (10,000,000 shares authorized, par value $0.001) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series C Preferred Stock (50,000 shares authorized and 2,500 shares issued and outstanding, par value $0.001) | 3 | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series D Preferred Stock (4,570 shares authorized and 1,334 shares issued and outstanding, par value $0.001) | 1 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series E Preferred Stock (3,000 shares authorized, -0- shares issued and outstanding, par value $0.001) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock (25,990,000,000 shares authorized, par value $0.001; 11,446,345,735 and 7,086,021,742 shares issued and outstanding as of September 30, 2025, and December 31, 2024, respectively) | 11446346 | 7086021 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treasury stock, at cost, 47,500 shares of Series C Preferred Stock and 18,667 shares of Series D Preferred Stock | (11249934) | (11249934) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock to be issued; 637,755 shares | 638 | 638 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid in capital | 194872729 | 198312711 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated deficit | (230427985) | (224868641) |
| &nbsp;&nbsp;&nbsp;Total Ozop Energy Solutions, Inc. stockholders' deficit | (35358202) | (30719201) |
| &nbsp;&nbsp;&nbsp;Noncontrolling interest | (784777) | (784777) |
| **TOTAL STOCKHOLDERS' DEFICIT** | (36142979) | (31503978) |
| **TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT** | $808124 | $1754165 |

---

The accompanying notes are an integral part of these consolidated financial statements.

**OZOP ENERGY SOLUTIONS, INC.**

**CONSOLIDATED STATEMENTS OF OPERATIONS**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Three Months Ended September 30,** | **For the Three Months Ended September 30,** | **For the Nine Months Ended September 30,** | **For the Nine Months Ended September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Revenue | $142840 | $74286 | $248828 | $1267980 |
| Cost of revenue | 91575 | 50863 | 170211 | 989955 |
| Gross profit | 51265 | 23423 | 78617 | 278025 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;General and administrative, related parties | 240000 | 240000 | 720000 | 720000 |
| &nbsp;&nbsp;&nbsp;General and administrative, other | 395840 | 723460 | 1699484 | 2020395 |
| Total operating expenses | 635840 | 963460 | 2419484 | 2740395 |
| Loss from continuing operations | (584575) | (940037) | (2340867) | (2462370) |
| Other (income) expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense | 1138538 | 1056866 | 2627912 | 3170633 |
| &nbsp;&nbsp;&nbsp;Loss (gain) on change in fair value of derivatives | 159312 | 96180 | 676815 | (549401) |
| &nbsp;&nbsp;&nbsp;Gain on litigation settlement |  |  |  | (271360) |
| &nbsp;&nbsp;&nbsp;Gain on sale of building to a related party | (86250) | - | (86250) | - |
| Total Other Expenses | 1211600 | 1153046 | 3218477 | 2349872 |
| Loss from continuing operations before income taxes | (1796175) | (2093083) | (5559344) | (4812242) |
| Income tax provision | - | - | - | - |
| Net loss from continuing operations | (1796175) | (2093083) | (5559344) | (4812242) |
| **Discontinued Operations:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Income from discontinued operations, net of tax | - | - | - | 3573 |
| Net loss | $(1796175) | $(2093083) | $(5559344) | $(4808669) |
| Loss from continuing operations per share of common stock basic and fully diluted | $(0.00) | $(0.00) | $(0.00) | $(0.00) |
| Income from discontinued operations per share of common stock basic and fully diluted | $0.00 | $0.00 | $0.00 | $0.00 |
| Loss per share basic and fully diluted | $(0.00) | $(0.00) | $(0.00) | $(0.00) |
| Weighted average shares outstanding basic and diluted | 10068559876 | 6630348082 | 8799894082 | 6180717578 |

---

The accompanying notes are an integral part of these consolidated financial statements.

**OZOP ENERGY SOLUTIONS, INC.**

**CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT**

**FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025**

**(Unaudited)**

---

| | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Common stock to be issued** | **Common stock to be issued** | **Series C Preferred Stock** | **Series C Preferred Stock** | **Series D Preferred Stock** | **Series D Preferred Stock** | **Common Stock** | **Common Stock** | | | | | |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Treasury**<br>**Stock** | **Additional Paid-in**<br>**Capital** | **Accumulated**<br>**Deficit** | **Noncontrolling**<br>**Interest** | **Total<br> Stockholders' Equity**<br>**(Deficit)** |
| Balances January 1, 2025 | 637755 | $638 | 2500 | $&nbsp;&nbsp;&nbsp;&nbsp; 3 | 1334 | $&nbsp;&nbsp;&nbsp;&nbsp; 1 | 7086021742 | $7086021 | $(11249934) | $198312711 | $(224868641) | $(784777) | $(31503978) |
| Issuance of shares of common stock sold, net of issuance costs of $10,552 |  |  |  |  |  |  | 1133822555 | 1133823 |  | (873018) |  |  | 260805 |
| Net loss | - | - | - | - | - | - | - | - | - | - | (1557171) | - | (1557171) |
| Balances March 31, 2025 | 637755 | 638 | 2500 | 3 | 1334 | 1 | 8219844297 | 8219844 | (11249934) | 197439693 | (226425812) | (784777) | (32800344) |
| Issuance of shares of common stock sold, net of issuance costs of $1,763 |  |  |  |  |  |  | 230771625 | 230772 |  | (195612) |  |  | 35160 |
| Issuance of common stock for services |  |  |  |  |  |  | 200000000 | 200000 |  | (160000) |  |  | 40000 |
| Warrants issued in connection with issuance of convertible debt |  |  |  |  |  |  |  |  |  | 127333 |  |  | 127333 |
| Issuance of common stock for accrued interest |  |  |  |  |  |  | 431665700 | 431666 |  | (397883) |  |  | 33783 |
| Net loss | - | - | - | - | - | - | - | - | - | - | (2205998) | - | (2205998) |
| Balances June 30, 2025 | 637755 | 638 | 2500 | 3 | 1334 | 1 | 9082281622 | 9082282 | (11249934) | 196813531 | (228631810) | (784777) | (34770066) |
| Issuance of shares of common stock sold, net of issuance costs of $12,946 |  |  |  |  |  |  | 964363313 | 964363 |  | (878566) |  |  | 85797 |
| Warrants issued in connection with issuance of convertible debt |  |  |  |  |  |  |  |  |  | 238750 |  |  | 238750 |
| Issuance of common stock for note payable and accrued interest |  |  |  |  |  |  | 1399700800 | 1399701 |  | (1300986) |  |  | 98715 |
| Net loss | - | - | - | - | - | - | - | - | - | - | (1796175) | - | (1796175) |
| Balances September 30, 2025 | 637755 | $638 | 2500 | $3 | 1334 | $1 | 11446345735 | $11446346 | $(11249934) | $194872729 | $(230427985) | $(784777) | $(36142979) |

---

The accompanying notes are an integral part of these consolidated financial statements.

**OZOP ENERGY SOLUTIONS, INC.**

**CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT**

**FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024**

**(Unaudited)**

---

| | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Common stock to be issued** | **Common stock to be issued** | **Series C Preferred Stock** | **Series C Preferred Stock** | **Series D Preferred Stock** | **Series D Preferred Stock** | **Common Stock** | **Common Stock** | | | | | |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Treasury**<br>**Stock** | **Additional<br> Paid-in**<br>**Capital** | **Accumulated**<br>**Deficit** | **Noncontrolling**<br>**Interest** | **Total<br> Stockholders' Equity**<br>**(Deficit)** |
| Balances January 1, 2024 | 637755 | $638 | 2500 | $3 | 1334 | $1 | 5481513400 | $5481513 | $(11249934) | $198704849 | $(218670480) | $(784777) | $(26518187) |
| Issuance of shares of common stock sold, net of issuance costs of $12,384 |  |  |  |  |  |  | 340303728 | 340304 |  | 10251 |  |  | 350555 |
| Net loss | - | - | - | - | - | - | - | - | - | - | (1423795) | - | (1423795) |
| Balances March 31, 2024 | 637755 | 638 | 2500 | 3 | 1334 | 1 | 5821817128 | 5821817 | (11249934) | 198715100 | (220094275) | (784777) | (27591427) |
| Issuance of shares of common stock sold, net of issuance costs of $19,193 |  |  |  |  |  |  | 806213965 | 806214 |  | (224492) |  |  | 581722 |
| Net loss | - | - | - | - | - | - | - | - | - | - | (1291791) | - | (1291791) |
| Balances June 30, 2024 | 637755 | 638 | 2500 | 3 | 1334 | 1 | 6628031093 | 6628031 | (11249934) | 198490608 | (221386066) | (784777) | (28301496) |
| Issuance of shares of common stock sold, net of issuance costs of $2,000 |  |  |  |  |  |  | 53290746 | 53291 |  | (6520) |  |  | 46771 |
| Net loss | - | - | - | - | - | - | - | - | - | - | (2093083) | - | (2093083) |
| Balances September 30, 2024 | 637755 | $638 | 2500 | $3 | 1334 | $1 | 6681321839 | $6681322 | $(11249934) | $198484088 | $(223479149) | $(784777) | $(30347808) |

---

The accompanying notes are an integral part of these consolidated financial statements.

**OZOP ENERGY SOLUTIONS, INC.**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **For the Nine Months Ended September 30,** | **For the Nine Months Ended September 30,** |
|  | **2025** | **2024** |
| **Cash flows from operating activities:** |  |  |
| &nbsp;&nbsp;&nbsp;Net loss from continuing operations | $(5559344) | $(4812242) |
| &nbsp;&nbsp;&nbsp;Net income from discontinued operations | - | 3573 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net loss | (5559344) | (4808669) |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net loss to net cash used in operating activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-cash interest expense | 340522 | 998970 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization and depreciation | 156685 | 160988 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss (gain) on fair value change of derivatives | 676815 | (549401) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of building to a related party | (86250) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock compensation expense | 40000 |  |
| &nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | (1784) | 137032 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventory | (119188) | 915977 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses | 47200 | (2648) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | 2462947 | 2192374 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Related party liabilities | 483000 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | 22710 | 9150 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | (120560) | (109527) |
| **Net cash used in continuing operations** | (1657247) | (1055754) |
| **Net cash used in discontinued operations** | - | (3573) |
| **Net cash used in operating activities** | (1657247) | (1059327) |
| **Cash flows from investing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;Purchase of office and computer equipment | (3490) | (11114) |
| &nbsp;&nbsp;&nbsp;Proceeds from sale of building to a related party | 100000 | - |
| **Net cash provided by (used in) investing activities** | 96510 | (11114) |
| **Cash flows from financing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from sale of common stock, net of costs | 381762 | 979048 |
| &nbsp;&nbsp;&nbsp;Proceeds from issuances of convertible notes payable, net | 573000 |  |
| &nbsp;&nbsp;&nbsp;Proceeds from issuances of notes payable, net | 150000 | - |
| **Net cash provided by financing activities** | 1104762 | 979048 |
| **Net decrease in cash** | (455975) | (91393) |
| **Cash, Beginning of period** | 797139 | 1446029 |
| **Cash, End of period** | $341164 | $1354636 |
| **Supplemental disclosure of cash flow information:** |  |  |
| &nbsp;&nbsp;&nbsp;Cash paid for interest | $- | $- |
| &nbsp;&nbsp;&nbsp;Cash paid for income taxes | $- | $- |
| **Schedule of non-cash Investing or Financing Activity:** |  |  |
| &nbsp;&nbsp;&nbsp;Right-of-use assets obtained in exchange for operating lease obligations | $103107 | $- |
| &nbsp;&nbsp;&nbsp;Forgiveness of related party liabilities for sale of building to a related party | $500000 | $- |
| &nbsp;&nbsp;&nbsp;Common stock issued for convertible note payable | $50000 | $- |
| &nbsp;&nbsp;&nbsp;Common stock issued for accrued interest | $82498 | $- |
| &nbsp;&nbsp;&nbsp;Convertible note in exchange for promissory note and accrued interest | $3558229 | $- |
| &nbsp;&nbsp;&nbsp;Debt discount related to derivative liability | $1232426 | $- |

---

The accompanying notes are an integral part of these consolidated financial statements.

**OZOP ENERGY SOLUTIONS, INC.**

**Notes to Consolidated Financial Statements**

**September 30, 2025**

**(Unaudited)**

**NOTE 1 - ORGANIZATION**

***Business***

Ozop Energy Solutions, Inc. (the" Company," "we," "us" or "our") was originally incorporated as Newmarkt Corp. on July 17, 2015, under the laws of the State of Nevada.

On July 10, 2020, the Company entered into a Stock Purchase Agreement (the "SPA") with Power Conversion Technologies, Inc., a Pennsylvania corporation ("PCTI"), and Catherine Chis ("Chis"), PCTI's Chief Executive Officer ("CEO") and its sole shareholder. Under the terms of the SPA, the Company acquired one thousand (1,000) shares of PCTI, which represents all of the outstanding shares of PCTI, from Chis in exchange for the issuance of 47,500 shares of the Company's Series C Preferred Stock, 18,667 shares of the Company's Series D Preferred Stock, and 500 shares of the Company's Series E Preferred Stock to Chis.

On October 29, 2020, the Company formed a new wholly owned subsidiary, Ozop Surgical Name Change Subsidiary, Inc., a Nevada corporation ("Merger Sub"). The Merger Sub was formed under the Nevada Revised Statutes for the sole purpose and effect of changing the Company's name to "Ozop Energy Solutions, Inc." That same day the Company entered into an Agreement and Plan of Merger (the "Merger Agreement") with the Merger Sub and filed Articles of Merger (the "Articles of Merger") with the Nevada Secretary of State, merging the Merger Sub into the Company, which were stamped effective as of November 3, 2020. As permitted by the Section 92.A.180 of the Nevada Revised Statutes, the sole purpose and effect of the filing of Articles of Merger was to change the name of the Company from Ozop Surgical Corp to "Ozop Energy Solutions, Inc."

On December 11, 2020, the Company formed Ozop Energy Systems, Inc. ("OES"), a Nevada corporation and a wholly owned subsidiary of the Company. OES was formed to be a manufacturer and distributor of renewable energy products.

On August 19, 2021, the Company formed Ozop Capital Partners, Inc. ("Ozop Capital"), a Delaware corporation and a wholly owned subsidiary of the Company. Brian Conway was appointed as the sole officer and director of Ozop Capital and has voting control of Ozop Capital.

On October 29, 2021, EV Insurance Company, Inc. ("EVCO") was formed as a captive insurance company in the State of Delaware. EVCO is a wholly owned subsidiary of Ozop Capital. On January 7, 2022, EVCO filed with New Castle County, Delaware DBA OZOP Plus.

On February 25, 2022, the Company formed Ozop Engineering and Design, Inc. ("OED") a Nevada corporation, as a wholly owned subsidiary of the Company. OED was formed to become a premier engineering and lighting control design firm. OED offers product and design support for lighting and solar projects with a focus on fast lead times and technical support. OED and our partners are able to offer the resources needed for lighting, solar and electrical design projects. OED will provide customers systems to coordinate the understanding of electrical usage with the relationship between lighting design and lighting controls, by developing more efficient ecofriendly designs. We work with architects, engineers, facility managers, electrical contractors and engineers.

On June 11, 2024, the Company formed Automated Room Controls, Inc. ("ARC") a Nevada corporation, as a wholly owned subsidiary of the Company. ARC was created to address a significant need in the lighting controls industry. ARC's personnel has extensive experience in lighting controls since 2012, bringing together IT specialists and lighting control experts. We believe that easy deployment and creative applications can transform lighting controls into essential tools for enhancing the utility and ambiance of any space. The Company's mission is to deliver cutting-edge technology that simplifies complex control needs, ensuring seamless integration and exceptional performance.

**NOTE 2 – GOING CONCERN AND MANAGEMENT'S PLANS**

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of September 30, 2025, the Company had an accumulated deficit of $230,427,985 and a working capital deficit of $36,273,834. As of September 30, 2025, the Company was in default of $17,725,000 plus accrued interest on debt instruments due to non-payment upon maturity dates. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for one year from the date of the issuance of these financial statements. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

**Management's Plans**

As a public company, Management believes it will be able to access the public equities market for fund raising for product development, sales and marketing and inventory requirements as we expand our distribution in the U.S. market.

On May 2, 2023, the Company entered into an Equity Financing Agreement (the "Financing Agreement") and Registration Rights Agreement (the "Registration Rights Agreement") with GHS. Under the terms of the Financing Agreement, GHS has agreed to provide the Company with up to $10,000,000 of funding upon effectiveness of a registration statement on Form S-1. Pursuant to the effectiveness of the registration statement on July 19, 2023, the Company has the right to deliver puts to GHS and GHS will be obligated to purchase shares of our common stock based on the investment amount specified in each put notice. The maximum amount that the Company shall be entitled to put to GHS in each put notice will not exceed two hundred fifty percent (250%) of the average of the daily trading dollar volume of the Company's common stock during the ten (10) trading days preceding the put, so long as such amount does not exceed 4.99% of the outstanding shares of the Company. Pursuant to the Financing Agreement, GHS and its affiliates will not be permitted to purchase, and the Company may not put shares of the Company's common stock to GHS that would result in GHS's beneficial ownership equaling more than 4.99% of the Company's outstanding common stock. The price of each put share shall be equal to eighty percent (80%) of the lowest daily volume weighted average price of the Company's common stock for the ten (10) consecutive trading days preceding the date on which the applicable put is delivered to GHS. No put will be made in an amount equaling less than $10,000 or greater than $750,000. Puts may be delivered by the Company to GHS until the earlier of twenty-four (24) months after the effectiveness of the registration statement on Form S-1 or the date on which GHS has purchased an aggregate of $10,000,000 worth of put shares.

On July 30, 2024, the Company receive a Notice of Effectiveness for the sale of up to Two Billion (2,000,000,000) shares of the Company's common stock to GHS, pursuant to the May 2, 2023, Financing Agreement and Registration Rights Agreement. The terms and conditions are similar to the terms and conditions of the July 19, 2023, registration statement. During the year ended December 31, 2024, the Company sold to GHS 457,990,649 shares of common stock and received $280,094, net of offering costs. For the three and nine months ended September 30, 2025, the Company sold GHS -0- and 1,364,594,180 shares of common stock respectively for proceeds of $-0- and $295,965 respectively net of offering costs.

On April 11, 2025, the Company entered into an Equity Financing Agreement (the "2025 Financing Agreement") and Registration Rights Agreement (the "2025 Registration Rights Agreement") with GHS. Under the terms of the Financing Agreement, GHS has agreed to provide the Company with up to $10,000,000 (the "Commitment Amount") of funding upon effectiveness of a registration statement on Form S-1. Pursuant to the effectiveness of the registration statement the Company has the right to deliver puts to GHS and GHS will be obligated to purchase shares of our common stock based on the investment amount specified in each put notice. The maximum amount that the Company shall be entitled to put to GHS in each put notice will not exceed three hundred percent (300%) of the average of the daily trading dollar volume of the Company's common stock during the ten (10) trading days preceding the put, so long as such amount does not exceed 4.99% of the outstanding shares of the Company. Pursuant to the 2025 Financing Agreement, GHS and its affiliates will not be permitted to purchase, and the Company may not put shares of the Company's common stock to GHS that would result in GHS's beneficial ownership equaling more than 4.99% of the Company's outstanding common stock. The price of each put share shall be equal to eighty percent (80%) of the lowest daily volume weighted average price of the Company's common stock for the ten (10) consecutive trading days preceding the date on which the applicable put is delivered to GHS. No put will be made in an amount equaling less than $10,000 or greater than $1,000,000. Puts may be delivered by the Company to GHS until the earlier of thirty-six (36) months after the effectiveness of the registration statement on Form S-1 or the date on which GHS has purchased an aggregate of $10,000,000 worth of put shares. The Company also agreed to issue to the investor as an equity incentive shares (the "Commitment Shares") equal to one quarter of one percent (0.25%) of the Commitment Amount, priced at a fixed price equaling ninety-five (95%) of the VWAP for the trading day preceding the execution of Agreements. This equates to $25,000, and as of the filing date of this quarterly report the shares have not been issued. On May 7, 2025, the Company receive a Notice of Effectiveness for the sale of up to Four Billion (4,000,000,000) shares of the Company's common stock to GHS, pursuant to the April 11, 2025, Financing Agreement and Registration Rights Agreement. For the three and nine months ended September 30, 2025, the Company sold GHS 964,363,313 shares of common stock for proceeds of $85,797 net of offering costs. Subsequent to September 30, 2025, the Company sold GHS 151,857,500 shares of common stock for proceeds of $10,406 net of offering costs.

OES operates in the renewable, electric vehicle ("EV"), energy storage and energy resiliency sectors. We are engaged in multiple business lines that include project development as well as equipment distribution.

*<u>Equipment Distributor:</u>* In April 2021, the Company signed a five-year lease (beginning June 1, 2021) of approximately 8,100 SF in California, for office and warehouse space to support the sales and distribution of our west coast operations. On February 22, 2023, with an effective date of March 1, 2023, the Company entered into a Sublease for a Single Subleasee Agreement (the "Sublease") with the landlord and a third party for the office and warehouse in Carlsbad California. Pursuant to the Sublease agreement, the third party will be responsible for all of the Company's lease obligations through May 31, 2026, the lease termination date. The Company and the subleasee have agreed to work together regarding any existing Company inventory in the facility.

*<u>Modular Energy Distribution System:</u>* The **NeoVolt<sup>™</sup>** System comprises the design engineering, installation, and operational methodologies as well as the financial arbitrage of how we produce, capture and distribute electrical energy for the EV markets. Our **NeoVolt<sup>TM</sup> System** offers (1) charging locations that can be installed with reduced delays, restricted areas or load limits and (2) EV charger electricity that is produced from renewable sources claiming little to no carbon footprint.

The Company has developed a business plan for NeoVolt™, a scalable battery storage solution that aims to relieve the stress on existing grid infrastructure by providing distributed energy storage. With the first stage of engineered technical drawings completed, we are advancing to stage two and preparing to construct the initial prototype or proof of concept (PoC). NeoVolt™ is designed with advanced features, including automatic adoption of connected devices and dynamic load balancing through a master-slave configuration. These capabilities enable NeoVolt™ to seamlessly integrate with and manage energy flows across multiple devices. Furthermore, the PoC is contingent upon recent advancements in EV charging and discharging standardizations, including on-board inverters and bi-directional capabilities, to ensure compatibility and efficiency in both residential and commercial applications.

OED specializes in lighting commissioning services. On September 27, 2024, OED signed an agreement with Leviton Manufacturing Co, Inc., to serve as a field service technician for their advanced lighting control systems.

Ozop Plus markets vehicle service contracts ("VSC's") for electric vehicles (EV's) that offer consumers to be able to purchase additional months and miles above the manufacturer's warranty and to also bring added value to EV owners by utilizing our partnerships and strengths in the energy market to offer unique and innovative services. Among EV owners' concerns are the EV battery repair and replacement costs, range anxiety, environmental responsibilities, roadside assistance, and the accelerated wear on additional components that EV vehicles experience. Management believes that the Ozop Plus marketed VSC's will give "peace of mind" to the EV buyer. On October 23, 2024, Ozop Capital Partners, Inc. entered into an agreement with Empire Auto Protect ("Empire"). Under the agreement, Empire will white label Royal Administration's Fully Charged VSC, to be marketed as Empire Plus. OZOP Plus will be ceded the battery premium portion of all of the Empire Plus VSC's contracted.

ARC has developed products to be an advanced lighting controls system, intricately engineered to integrate sophisticated wired and wireless technologies. At its core, it employs a hybrid network topology that facilitates both resilient wired connections and flexible wireless communications, making it suitable for complex infrastructural environments. The system is equipped with an array of sensors and control nodes, enabling precise light management and energy usage monitoring. With support for protocols such as DALI and Zigbee, alongside the capability for seamless integration with IoT platforms, ARC offers a comprehensive solution for intricate lighting networks. This system is designed not just for control and efficiency, but also for adaptability to diverse architectural and electrical layouts, embodying a technical solution for advanced, energy-conscious lighting management.

**NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

***Basis of Presentation***

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company's management, the accompanying unaudited consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of September 30, 2025, and the results of operations and cash flows for the periods presented. The results of operations for the three and nine months ended September 30, 2025, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2024, included in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on April 15, 2025.

The unaudited consolidated financial statements include the accounts of the Company and the Company's wholly owned subsidiaries Ozop Energy Systems, Inc. ("OES"), Ozop Capital Partners, Inc. ("Ozop Capital"), Ozop Engineering and Design, Inc. ("OED), Automated Room Controls, Inc. ("ARC"), Power Conversion Technologies, Inc. ("PCTI"), Ozop LLC, Ozop HK and Spinus, LLC ("Spinus"). All intercompany accounts and transactions have been eliminated in consolidation.

***Use of Estimates***

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.

***Cash and Cash Equivalents***

The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash is maintained at a major financial institution. Accounts held at U.S. financial institutions are insured by the FDIC up to $250,000. The Company is exposed to credit risk in the event of default by the financial institutions or the issuers of these investments to the extent the amounts on deposit or invested are in excess of amounts that are insured. Cash and cash equivalent balances may, at certain times, exceed federally insured limits. The Company has no cash equivalents at September 30, 2025, and December 31, 2024. The amount in excess of the FDIC insurance as of September 30, 2025, and December 31, 2024, was approximately $-0-, and $223,000, respectively. The Company has not experienced any losses on these accounts and management believes, based upon the quality of this major financial institution, that the credit risk with regard to these deposits is not significant.

 ****

***Sales Concentration and credit risk***

Following is a summary of customers who accounted for more than ten percent (10%) of the Company's revenues for the three and nine months ended September 30, 2025, and 2024, and their accounts receivable balance as of September 30, 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | Sales % Three<br> Months<br> Ended <br> September<br> 30, 2025 | Sales % <br> Nine<br> Months<br> Ended <br> September<br> 30, 2025 | Sales % Three<br> Months<br> Ended <br> September<br> 30, 2024 | Sales % <br> Nine<br> Months<br> Ended<br> September<br> 30, 2024 | Accounts<br> receivable<br> balance <br> September<br> 30, 2025 |
| Customer A | 46.7% | 51.6% | N/A | N/A | $30738 |
| Customer B | 22.8% | 13.1% | N/A | N/A | $24429 |
| Customer C | 13.8% | N/A | N/A | N/A | $- |
| Customer D | 10.5% | N/A | N/A | N/A | $14095 |
| Customer E | N/A | N/A | 32.6% | N/A | $- |
| Customer F | N/A | N/A | 23.6% | N/A | $- |
| Customer G | N/A | N/A | 16.4% | 18.7% | $- |
| Customer H | N/A | N/A | 10.1% | N/A | $- |
| Customer I | N/A | N/A | N/A | 67.9% | $- |

---

***Accounts Receivable***

The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience. As of September 30, 2025, three customers represented 38%, 30%, and 17%, respectively of our outstanding accounts receivable. As of December 31, 2024, two customers represented approximately 60% and 22%, respectively of our outstanding accounts receivable.

***Inventory***

Inventories are valued at the lower of cost or net realizable value, with cost determined on the first-in, first-out basis. Inventory costs consist of finished goods. In evaluating the net realizable value of inventory, management also considers, if applicable, other factors, including known trends, market conditions, currency exchange rates and other such issues. Finished goods inventories as of September 30, 2025, and December 31, 2024, were $129,861 and $10,673, respectively. There are no inventory markdowns for the three and nine months ended September 30, 2025, and 2024.

***Purchase concentration***

ARC began purchasing inventory during the nine months ended September 30, 2025. For the three and nine months ended September 30, 2025, ARC purchased $30,570 and $197,106 of product, respectively. For the three months ended September 30, 2025, one vendor represented 93%. For the nine months ended September 30, 2025, two vendors represented 77% and 18% respectively. OES purchases finished renewable energy products from its' suppliers. For the three and nine months ended September 30, 2025, and 2024, OES made no purchases.

***Property, plant, and equipment***

Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets.

The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows:

Building 10-25 years <br> Office furniture and equipment 3-5 years <br> Warehouse equipment 7 years

 ****

***Revenue Recognition***

The Company recognizes revenue in accordance with ASC 606, from the commercial sales of products or providing services by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. The Company has no outstanding contracts with any of its' customers. The Company recognizes revenue when title, ownership, and risk of loss pass to the customer, all of which occurs upon shipment or delivery of the product and is based on the applicable shipping terms for product sales or upon delivery of service to the customer for installation services. Any advance payments are recorded as current liability until revenue is recognized.

For product sales contracts with customers, ownership of the goods and associated revenue are transferred to customers at a point in time, generally upon shipment of a product to the customer or receipt of the product by the customer and without significant judgments. For the periods covered herein, we did not have post shipment obligations such as training or installation, customer acceptance provisions, credits and discounts, rebates and price protection, or other similar privileges.

For installation services contracts with customers, the Company invoices the customer upon completion of the job and recognizes revenue based on the invoiced amount.

The following table disaggregates our revenue by major source for the three and nine months ended September 30, 2025, and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three months ended <br> September 30, | Three months ended <br> September 30, | Nine months ended <br> September 30, | Nine months ended <br> September 30, |
|  | 2025 | 2024 | 2025 | 2024 |
| Sourced and distributed products | $75986 | $51104 | $98464 | $1005878 |
| OED Installations | 66854 | 23182 | 150364 | 262102 |
| Total | $142840 | $74286 | $248828 | $1267980 |

---

***Advertising and Marketing Expenses***

The Company expenses advertising and marketing costs as incurred. For the three and nine months ended September 30, 2025, the Company recorded advertising and marketing expenses of $5,787 and $31,155, respectively, compared to $6,805 and $35,354 for the three and nine months ended September 30, 2024, respectively.

***Research and Development***

Costs and expenses that can be clearly identified as research and development are charged to expense as incurred. For the three and nine months ended September 30, 2025, the Company recorded $-0- and $44,872 of research and development expenses, respectively. For the three and nine months ended September 30, 2024, the Company recorded $87,778 and $115,262 of research and development expenses, respectively

***Convertible Instruments***

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities.

Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of this note transaction and the effective conversion price embedded in this note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.

The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities.

***Discontinued Operations***

In accordance with ASC 205-20 *Presentation of Financial Statements: Discontinued Operations*, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity's operations and financial results when the components of an entity meet the criteria in paragraph 205-20-45-10. In the period in which the component meets held-for-sale or discontinued operations criteria the major current assets, other assets, current liabilities, and noncurrent liabilities shall be reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), shall be reported as components of net income (loss) separate from the net income (loss) of continuing operations.

On September 1, 2022, the BOD of the Company authorized the filing of a Chapter 7 proceeding which meets the definition of a discontinued operation. Accordingly, the operating results of PCTI are reported as net income (loss) from discontinued operations in the accompanying unaudited consolidated financial statements for the three and nine months ended September 30, 2025, and 2024. For additional information, see Note 14- Discontinued Operations.

***Distinguishing Liabilities from Equity***

The Company relies on the guidance provided by ASC Topic 480, *Distinguishing Liabilities from Equity*, to classify certain redeemable and/or convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.

Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet ("temporary equity"). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.

Our CEO and Chairman holds sufficient shares of the Company's voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO and Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company.

*Initial Measurement*

The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received.

 

 

*Subsequent Measurement – Financial Instruments Classified as Liabilities*

The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in the fair value of its financial instruments classified as liabilities are recorded as other income (expenses).

 ****

***Fair Value of Financial Instruments***

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

The following are the hierarchical levels of inputs to measure fair value:

● Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.

● Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

● Level 3 - Unobservable inputs reflecting the Company's assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

From time to time, certain of the Company's embedded conversion features on debt and outstanding warrants have been treated as derivative liabilities for accounting purposes under ASC 815 due to insufficient authorized shares to fully settle conversion features of the instruments if exercised. In this case, the Company utilized the latest inception date sequencing method to reclassify outstanding instruments as derivative instruments. These contracts were recognized at fair value with changes in fair value recognized in earnings until such time as the conditions giving rise to such derivative liability classification were settled.

The carrying amounts of the Company's financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses and certain notes payable approximate their fair values because of the short maturity of these instruments.

The following table represents the Company's derivative instruments that are measured at fair value on a recurring basis as of September 30, 2025, and December 31, 2024, for each fair value hierarchy level:

---

| | | |
|:---|:---|:---|
| September 30, 2025 | Derivative<br> Liabilities | Total |
| Level I | $- | $- |
| Level II | $- | $- |
| Level III | $1753651 | $1753651 |

---

---

| | | |
|:---|:---|:---|
| December 31, 2024 | Derivative<br> Liabilities | Total |
| Level I | $- | $- |
| Level II | $- | $- |
| Level III | $210493 | $210493 |

---

 ****

***Leases***

The Company accounts for leases under ASU 2016-02 (see Note 13), applying the package of practical expedients to leases that commenced before the effective date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract the Company assess whether the contract is, or contains, a lease. Our assessment is based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether we have the right to direct the use of the asset. We allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments.

Operating lease ROU assets represent the right to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company used an incremental borrowing rate of 7.5%, for the existing lease, based on the information available at the adoption date in determining the present value of future payments. Operating lease expense is recognized pursuant to on a straight-line basis over the lease term and is included in rent in the consolidated statements of operations.

***Income Taxes***

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the deferred tax assets will not be realized.

Tax benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting periods presented.

***Segment Policy***

The Company uses the "management approach" in determining reportable operating segments. The management approach considers the internal organization and reporting used by the Company's chief operating decision maker ("CODM"), who is our chief executive officer, for making operating decisions and assessing performance as the source for determining the Company's reportable segments. Management, including the chief operating decision maker, reviews operating results solely by monthly revenue and operating results of the Company and, as such, the Company has determined that the Company has one operating segment (renewable energy) as defined by ASC Topic 280 "Segment Reporting".

***Earnings (Loss) Per Share***

The Company reports earnings (loss) per share in accordance with ASC 260, "Earnings per Share." Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. As of September 30, 2025, and 2024, the Company's dilutive securities are convertible into approximately 78,233,944,904 and 11,610,545,586, respectively, shares of common stock. The following table represents the classes of dilutive securities as of September 30, 2025, and 2024:

---

| | | |
|:---|:---|:---|
|  | **September 30,<br> 2025** | **September 30,<br> 2024** |
| Convertible preferred stock (1) | 17169518603 | 10021982759 |
| Unexercised common stock purchase warrants (1) | 6685000000 | 807024518 |
| Convertible notes payable (1) | 46176588548 | 68791734 |
| Promissory notes payable (1) | 8202837753 | 712746575 |
|  | 78233944904 | 11610545586 |

---

(1) The
 potentially dilutive shares included in the above table are limited whereby the conversion or exercise cannot result in the beneficial
 owner holding more than 4.99 % of the then outstanding shares of common stock subsequent to any conversion or exercise. These shares
 were excluded from the diluted per share calculation because the effect of including these potential shares was anti-dilutive due
 to the Company's net loss position.

 ****

***Recent Accounting Pronouncements***

From time-to-time new accounting pronouncements are issued by the Financial Accounting Standards Board ("FASB") or other standard setting bodies that may have an impact on the Company's accounting and reporting. Unless otherwise discussed, the Company believes that other recently issued accounting pronouncements and other authoritative guidance for which the effective date is in the future will not have an impact on its accounting or reporting or that such impact will not be material to its financial position, results of operations and cash flows when implemented.

*Recently adopted accounting pronouncements*

Segment Reporting

In November 2023, the FASB issued Accounting Standards Update (ASU) No. 2023-07, Improvements to Reportable Segment Disclosures (Topic 280). This ASU updates reportable segment disclosure requirements by requiring disclosures of significant reportable segment expenses that are regularly provided to the CODM and included within each reported measure of a segment's profit or loss. This ASU also requires disclosure of the title and position of the individual identified as the CODM and an explanation of how the CODM uses the reported measures of a segment's profit or loss in assessing segment performance and deciding how to allocate resources. The ASU is effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. We adopted this ASU retrospectively on December 31, 2024. The adoption of ASU 2023-07 did not have a significant impact on the Company's consolidated financial statements and related disclosures.

*Recently issued accounting pronouncements not yet adopted*

Income Taxes

In December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures ("ASU 2023-09"). ASU 2023-09 is intended to improve income tax disclosures primarily through enhanced disclosure of income tax rate reconciliation items, and disaggregation of income (loss) from continuing operations, income tax expense (benefit) and income taxes paid, net disclosures by federal, state and foreign jurisdictions, among others. ASU 2023-09 is effective for annual reporting periods beginning after December 15, 2024, and early adoption is permitted. The Company will adopt the standard on the effective date in our annual reporting for the year ended December 31, 2025. The standard can be applied either prospectively or retrospectively.

Disaggregation of Income Statement Expenses

In November 2024, the FASB issued ASU No. 2024-03, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses", which requires disaggregated disclosure of income statement expenses for public business entities. ASU 2024-03 requires new financial statement disclosures in tabular format, disaggregating information about prescribed categories underlying any relevant income statement expense caption. The prescribed categories include, among other things, purchases of inventory, employee compensation, depreciation, and intangible asset amortization. Additionally, entities must disclose the total amount of selling expenses and, in annual reporting periods, an entity's definition of selling expenses. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and for interim reporting periods within fiscal years beginning after December 15, 2027. The guidance can be applied prospectively with an option for retrospective application. Early adoption is also permitted. We are currently evaluating the provisions of this ASU.

Financial Instruments – Measurement of Credit Losses for Accounts Receivable and Contract Assets

In July 2025, the FASB issued ASU No. 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. The amendments in this update provide a practical expedient permitting an entity to assume that conditions at the balance sheet date remain unchanged over the life of the asset when estimating expected credit losses for current classified accounts receivable and contract assets. This update is effective for annual periods beginning after December 15, 2025, including interim periods within those fiscal years. Adoption of this ASU can be applied prospectively for reporting periods after its effective date. Early adoption is permitted. The Company is currently evaluating the impact that ASU 2025-05 will have on the consolidated financial statements.

**NOTE 4 – PROPERTY AND EQUIPMENT**

The following table summarizes the Company's property and equipment:

---

| | | |
|:---|:---|:---|
|  | **September 30,<br> 2025** | **December 31,<br> 2024** |
| Office equipment | $239336 | $235846 |
| Building and building improvements |  | 600000 |
| Less: Accumulated depreciation | (225308) | (274447) |
| Property and Equipment, Net | $14028 | $561399 |

---

During the three and nine months ended September 30, 2025, the Company sold its building to an entity controlled by the Company's CEO. The sale price was $600,000 and the Company received $100,000 in cash and the buyer forgave $500,000 of related party accrued and unpaid management fees owed to the CEO (see Note 9). The Company recorded a gain on the sale of the building to a related party of $86,250, which is included in the Statement of Operations for the three and nine months ended September 30, 2025. After the building was sold to the related party, the Company leased back the building from the same related party in September 2025 for a three-year lease with a monthly lease payment of $5,000 beginning on September 1, 2026, which was accounted for as a sale and leaseback transaction (see Note 13).

Depreciation expense was $8,434 and $37,111 for the three and nine months ended September 30, 2025, respectively, and $16,047 and $52,716 for the three and nine months ended September 30, 2024, respectively.

**NOTE 5 - CONVERTIBLE NOTES PAYABLE**

On July 10, 2020, PCTI (the accounting acquirer) assumed the balance of a past-due 15% convertible note issued by the Company on September 13, 2017. As of September 30, 2025, and December 31, 2024, the outstanding principal balance of this note was $25,000.

On May 28, 2025 (the "Issue Date"), the Company entered into a 12%, $200,000 face value promissory note (the "May 2025 Note"), with a third-party (the "Holder") due June 2, 2026 (the "Maturity Date"). The Holder shall have the right from time to time, and at any time following, convert all or any part of the outstanding and unpaid principal, interest and any other amounts due into fully paid and non-assessable shares of common stock of the Company. The per share conversion price into which Principal Amount and interest (including any Default Interest) under this Note shall be convertible into shares of Common Stock hereunder as further described in this Note (the "Conversion Price") shall equal the Market Price (as defined in the Note), subject to adjustment as provided in this Note. "Market Price" shall mean 70% of the lowest Trading Price (as defined below) for the Common Stock during the five (5) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date. "Trading Price" means, for any security as of any date, the volume weighted average price on the Principal Market as reported by a reliable reporting service ("Reporting Service") designated by the Holder (i.e. Quotestream or Bloomberg). The Company received proceeds of $191,000 on June 3, 2025, and the Company reimbursed the investor for expenses for legal fees and due diligence of $9,000. For the three and nine months ended September 30, 2025, amortization of the costs of $2,250 and $3,000, respectively, was charged to interest expense. In conjunction with this Note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 1,000,000,000 shares of common stock at an exercise price of $0.0002, subject to adjustments and expires on the five-year anniversary of the Issue Date. The warrants issued resulted in a debt discount of $127,333. For the three and nine months ended September 30, 2025, amortization of the debt discount of $31,833 and $42,444 was charged to interest expense.

On July 15, 2025 (the "Issue Date"), the Company entered into a 12%, $200,000 face value promissory note (the "July 2025 Note") with a third-party (the "Holder") due July 14, 2026 (the "Maturity Date"). The July 2025 Note is with the same lender and the same terms as the May 2025 Note. The Company received proceeds of $191,000 on July 15, 2025, and the Company reimbursed the investor for expenses for legal fees and due diligence of $9,000. For the three and nine months ended September 30, 2025, amortization of the costs of $1,875 was charged to interest expense. In conjunction with this Note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 1,000,000,000 shares of common stock at an exercise price of $0.0002, subject to adjustments and expires on the five-year anniversary of the Issue Date. The warrants issued resulted in a debt discount of $143,250. For the three and nine months ended September 30, 2025, amortization of the debt discount of $29,844 was charged to interest expense.

On September 24, 2025 (the "Issue Date"), the Company entered into a 12%, $200,000 face value promissory note (the "September 2025 Note") with a third-party (the "Holder") due September 23, 2026 (the "Maturity Date"). The September 2025 Note is with the same lender and the same terms as the May 2025 Note. The Company received proceeds of $191,000 on September 24, 2025, and the Company reimbursed the investor for expenses for legal fees and due diligence of $9,000. For the three and nine months ended September 30, 2025, amortization of the costs of $187 was charged to interest expense. In conjunction with this Note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 1,000,000,000 shares of common stock at an exercise price of $0.0002, subject to adjustments and expires on the five-year anniversary of the Issue Date. The warrants issued resulted in a debt discount of $95,500. For the three and nine months ended September 30, 2025, amortization of the debt discount of $1,990 was charged to interest expense.

On July 31, 2025, the Company entered into an Exchange Agreement, whereby, the Company agreed that the holder may exchange any part or all of the outstanding principal and interest (the Exchange Amount) of the promissory note entered into on February 9, 2021 (see Note 7) at any time and from time to time into the number of common shares equal to the Exchange Amount divided by the lowest trading price from the previous ten (10) trading days, and to extend the maturity date of the note to March 31, 2026. The Company determined the Exchange Agreement represented a substantial modification to the existing debt. Accordingly, the Company extinguished the promissory note dated February 9, 2021, as well as the accrued interest as of July 31, 2025, and recorded two convertible notes, one for the principal amount of $2,200,000 with an annual interest rate of 15% and one for the accrued interest of $1,358,229 with no additional interest in the future. The embedded conversion features for these convertible notes were accounted for as derivatives, which were valued at $866,343 by the Monte Carlo option pricing method (see Note 6), and were recorded as debt discount that will be amortized through the new maturity date of the note of March 31, 2026. On August 20, 2025, the holder converted $50,000 of the note into 500,000,000 shares of common stock at a conversion price of $0.0001. For the three and nine months ended September 30, 2025, amortization of the debt discount of $216,586 was charged to interest expense. As of September 30, 2025, the outstanding principal balance of the two convertible notes was $3,508,229, with a carrying value of $2,858,472, net of unamortized discount of $649,757 as of September 30, 2025.

The following table summarizes the Company's convertible notes payable:

---

| | | |
|:---|:---|:---|
|  | **Nine Months ended September 30,<br> 2025** | **Year ended December 31,<br> 2024** |
| Beginning balance | $25000 | $25000 |
| New convertible note issuances | 600000 |  |
| Convertible notes issued in exchange for promissory note and accrued interest as a result of loan modification (see Note 7) | 3558229 |  |
| Less: conversion | (50000) |  |
| Less: unamortized discounts | (963499) | - |
| Ending balance, net of discounts | $3169730 | $25000 |

---

**NOTE 6 – DERIVATIVE LIABILITIES**

The Company has adopted Accounting Standards Update ("ASU") 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20), which removed certain separation models in Subtopic 470-20. Under the amendments in ASU 2020-06, the embedded conversion features no longer are separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost.

At any given time, certain of the Company's embedded conversion features on debt and outstanding warrants may be treated as derivative liabilities for accounting purposes under ASC 815-40 due to insufficient authorized shares to settle these outstanding contracts. Pursuant to SEC staff guidance that permits a sequencing approach based on the use of ASC 815-15-25 which provides guidance for contracts that permit partial net share settlement. The sequencing approach may be applied in one of two ways: contracts may be evaluated based on (1) earliest issuance date or (2) latest maturity date. Pursuant to the sequencing approach, the Company evaluates its contracts based upon the latest maturity date.

The Company valued the derivative liabilities at September 30, 2025, and December 31, 2024, at $1,753,651 and $210,493 respectively. In connection with the Exchange Agreement (see Note 5), on July 31, 2025, the Company recorded an initial derivative liability of $866,343, with the offset to debt discount. The Company used the Monte Carlo simulation valuation model with the following assumptions as of July 31, 2025, risk free interest rates at 4.24% and volatility of 300%. For the derivative liability associated with convertible notes, the Company used the Monte Carlo simulation valuation model with the following assumptions as of September 30, 2025, and December 31, 2024, risk free interest rates at 3.83% and 4.24%, respectively, and volatility of 385%, and 101%, respectively.

The following assumptions were utilized in the Black-Scholes valuation of outstanding warrants as of September 30, 2025, and December 31, 2024, risk free interest rate of 3.38% to 3.83%, and 4.18% to 4.25%, respectively, volatility of 385% to 527%, and 121% to 146%, respectively, and exercise prices of $0.0002 to $0.008, and $0.0019 to $0.008, respectively.

A summary of the activity related to derivative liabilities for the nine months ended September 30, 2025, and 2024, is as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **Derivative liabilities**<br> **associated with warrants** | **Derivative liabilities**<br> **associated with convertible notes** | **Total derivative liabilities** |
| Balance January 1, 2025 | $176103 | $34390 | $210493 |
| Fair value of issuances during the period | 1200000 | 866343 | 2066343 |
| Change in fair value | (770208) | 247023 | (523185) |
| Balance September 30, 2025 | $605895 | $1147756 | $1753651 |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **Derivative liabilities**<br> **associated with warrants** | **Derivative liabilities**<br> **associated with convertible notes** | **Total derivative liabilities** |
| Balance January 1, 2024 | $1187076 | $29002 | $1216078 |
| Change in fair value | (555497) | 6096 | (549401) |
| Balance September 30, 2024 | $631579 | $35098 | $666677 |

---

**NOTE 7 – NOTES PAYABLE**

The Company has the following notes payable outstanding:

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025** | **December 31, 2024** |
| Note payable, interest at 8% or 20% (if default), matured January 5, 2020, in default | $45000 | $45000 |
| Other, due on demand, interest at 6%, currently in default | 50000 | 50000 |
| Note payable $750,000 face value, interest at 12% or 24% (if default), matured August 24, 2021, in default | 375000 | 375000 |
| Note payable $389,423 face value, interest at 15%, matured November 6, 2025, net of discount of $5,537 (2025) and $48,259 (2024) | 383886 | 341164 |
| Note payable $1,000,000 face value, interest at 12% or 24% (if default), matured November 13, 2021, in default | 1000000 | 1000000 |
| Note payable $2,200,000 face value, interest at 15%, matures March 31, 2026, the September 30, 2025 balance of $2,150,000 was included and presented under convertible notes payable as a result of loan modification (see Note 5) |  | 2200000 |
| Note payable $11,110,000 face value, interest at 15%, matured October 31, 2024, in default | 11110000 | 11110000 |
| Note payable $3,300,000 face value, interest at 15%, matured October 31, 2024, in default | 3300000 | 3300000 |
| Note payable $3,020,000 face value, matured March 31, 2023, in default | 1820000 | 1820000 |
| Note payable $165,000 face value, interest at 15%, matures August 13, 2026, net of discount of $13,125 | 151875 | - |
| Sub-total notes payable, net of discount | 18235761 | 20241164 |
| Less long-term portion, net of discount | - | - |
| Current portion of notes payable, net of discount | $18235761 | $20241164 |

---

On August 13, 2025, the Company entered into a 15% Secured Promissory Note for $165,000 with a third-party lender and a maturity date of August 13, 2026. The Company received proceeds of $150,000 on August 14, 2025, and the Company reimbursed the investor for expenses for legal fees and due diligence of $15,000 (original issue discount or "OID"). This note shall be senior secured by any and all assets of the Company. For the three and nine months ended September 30, 2025, $1,875 was charged to interest expense. As of September 30, 2025, the outstanding principal balance of this note was $165,000 with a carrying value of $151,875, net of unamortized discounts of $13,125 as of September 30, 2025.

On November 11, 2022, the Company entered into a non-interest bearing, $3,020,000 face value promissory note with a third-party lender with scheduled weekly payments and a maturity date of March 31, 2023. In exchange for the issuance of the $3,020,000 note, inclusive of an original issue discount of $250,000, and the reclass of $260,000 from accounts payable and accrued expenses the Company received proceeds of $2,510,000 on November 11, 2022, from the lender. Through September 30, 2025, the Company has repaid $1,200,000 of the principal of the note. As of September 30, 2025, and December 31, 2024, the outstanding principal balance of this note was 1,820,000. The Company is in default on the weekly payments. The Company is currently in discussions with the lender regarding an extension of the maturity date.

On December 7, 2021, the Company entered into a 12%, $3,300,000 face value promissory note with a third- party lender with a maturity date of December 7, 2022. In exchange for the issuance of the $3,300,000 note, inclusive of an original issue discount of $300,000, the Company received proceeds of $3,000,000 on December 13, 2021, from the lender. In conjunction with the note, the Company issued a warrant to purchase 75,000,000 shares of common stock at $0.039 per share (subject to adjustments) with an expiry date on the three- year anniversary of the note. On October 31, 2022, the maturity date of the note was extended to October 31, 2024, and the interest rate was increased to 15% per annum. The Company issued 75,000,000 warrants at an exercise price of $0.0067 and with an expiration of October 31, 2025, in exchange for the extension. The warrants were valued at $510,000 by the Black-Scholes option pricing method and have been amortized through the new maturity date of the note. The Company determined that this transaction was a modification of the existing note. For the three and nine months ended September 30, 2025, there was no charge to interest expense, and $63,750 and $191,250, respectively, was charged to interest expense for the three and nine months ended September 30, 2024. As of September 30, 2025, and December 31, 2024, the outstanding principal balance of this note was $3,300,000. The Company is currently in discussions with the lender regarding an extension of the maturity date.

On March 17, 2021, the Company entered into a 12%, $11,110,000 face value promissory note with a third- party lender with a maturity date of March 17, 2022. In exchange for the issuance of the $11,110,000 note, inclusive of an original issue discount of $1,000,000 and lender costs of $110,000, the Company received proceeds of $10,000,000 on March 23, 2021, from the lender. In conjunction with the note, the Company issued a warrant to purchase 250,000,000 shares of common stock at $0.13 per share (subject to adjustments) with an expiry date on the three- year anniversary of the note. On October 31, 2022, the maturity date of the note was extended to October 31, 2024, and the interest rate was increased to 15% per annum. The Company issued 250,000,000 warrants at an exercise price of $0.0067 and with an expiration of October 31, 2025, in exchange for the extension. The warrants were valued at $1,700,000 by the Black-Scholes option pricing method and have been amortized through the new maturity date of the note. The Company determined that this transaction was a modification of the existing note. For the three and nine months ended September 30, 2025, there was no charge to interest expense. For the three and nine months ended September 30, 2024, $212,500 and $637,500, respectively, was charged to interest expense. As of September 30, 2025, and December 31, 2024, the outstanding principal balance of this note was $11,110,000. The Company is currently in discussions with the lender regarding an extension of the maturity date.

On February 9, 2021, the Company entered into a 12%, $2,200,000 face value promissory note with a third- party lender with a maturity date of February 9, 2022. In exchange for the issuance of the $2,200,000 note, inclusive of an original issue discount of $200,000, the Company received proceeds of $2,000,000 on February 16, 2021, from the lender. In conjunction with the note, the Company issued a warrant to purchase 50,000,000 shares of common stock at $0.15 per share (subject to adjustments) with an expiry date on the three- year anniversary of the note. On October 31, 2022, the maturity date of the note was extended to October 31, 2024, and the interest rate was increased to 15% per annum. The Company issued 50,000,000 warrants at an exercise price of $0.0067 and with an expiration of October 31, 2025, in exchange for the extension. The warrants were valued at $340,000 by the Black-Scholes option pricing method and have been amortized through the new maturity date of the note. The Company determined that this transaction was a modification of the existing note. On July 31, 2025, the Company entered into an Exchange Agreement (see Note 5), whereby, the Company agreed that the holder may exchange any part or all of the outstanding principal and interest (the Exchange Amount) at any time and from time to time into the number of common shares equal to the Exchange Amount divided by the lowest trading price from the previous ten (10) trading days, and to extend the maturity date of the note to March 31, 2026. As a result, this note (with all of its outstanding principal and accrued interest as of July 31, 2025) was exchanged into a convertible note. The Company determined the Exchange Agreement represented a substantial modification to the existing debt. Accordingly, the Company extinguished the promissory note dated February 9, 2021, as well as the accrued interest as of July 31, 2025, and recorded two convertible notes, one for the principal amount of $2,200,000 (at an annual interest rate of 15%) and one for the accrued interest of $1,358,229 (with no additional interest in the future). For the three and nine months ended September 30, 2024, $42,500 and $127,500, respectively, was charged to interest expense. As of September 30, 2025, the outstanding principal balance of this note of $2,150,000 was included and presented under convertible notes payable. As of December 31, 2024, the outstanding principal balance of this note was $2,200,000.

On November 13, 2020, the Company entered into a 12%, $1,000,000 face value promissory note with a third-party due November 13, 2021. Principal payments shall be made in six instalments of $166,667 commencing 180 days from the issue date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the maturity date. The Company received proceeds of $890,000 on November 20, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $110,000. In conjunction with this note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 125,000,000 shares of common stock at an exercise price of $0.008, subject to adjustments and expires on the five-year anniversary of the issue date. This note is in default and the interest rate from the date of default is the lesser of 24% or the highest amount permitted by law. As of September 30, 2025, and December 31, 2024, the outstanding principal balance of this note was $1,000,000. As of September 30, 2025, and December 31, 2024, the accrued interest is $1,035,452 and $855,452, respectively. The Company is in discussions with the lender regarding the extension of the maturity date of this note.

On November 6, 2020, the Company entered into a Settlement Agreement with the holder of $120,000 of convertible notes with accrued and unpaid interest of $8,716 and a $210,000 Promissory Noted dated June 23, 2020, with accrued and unpaid interest of $15,707. The Company issued a new 12% Promissory Note with a face value of $389,423 and a maturity date of November 6, 2023, and was in default. In conjunction with this settlement, the Company issued a warrant to purchase 60,000,000 shares of common stock at an exercise price of $0.0075, subject to adjustments and expires on the five-year anniversary of the issue date. The Company analyzed the transaction and concluded that this was a modification to the existing debt. The investor exercised the warrant on January 14, 2021. On November 6, 2023, the maturity date of the note was extended to November 6, 2025, and the interest rate was increased to 15% per annum. The Company issued 60,000,000 warrants at an exercise price of $0.0019 and with an expiration of November 6, 2026, in exchange for the extension. The warrants were valued at $113,921 by the Black-Scholes option pricing method and are being amortized through the new maturity date of the note. The Company determined that this transaction was a modification of the existing note. For the three and nine months ended September 30, 2025, and 2024, $14,242 and $42,722, respectively, was charged to interest expense. As of September 30, 2025, and December 31, 2024, the outstanding principal balance of this note was $389,423 with a carrying value of $383,886 and $341,164, respectively, net of unamortized discounts of $5,537 and $48,259, respectively, as of September 30, 2025, and December 31, 2024.

On August 24, 2020 (the "Issue Date"), the Company entered into a 12%, $750,000 face value promissory note with a third-party (the "Holder") due August 24, 2021 (the "Maturity Date"). Principal payments shall be made in six instalments of $125,000 commencing 180 days from the Issue Date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the Maturity Date. The Holder shall have the right from time to time, and at any time following an event of default, as defined on the agreement, to convert all or any part of the outstanding and unpaid principal, interest and any other amounts due into fully paid and non-assessable shares of common stock of the Company, at the lower of i) the Trading Price (as defined in the agreement) during the previous five trading days prior to the Issuance Date or ii) the volume weighted average price during the five trading days ending on the day preceding the conversion date. The Company received proceeds of $663,000 on August 25, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $87,000. In conjunction with this Note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 122,950,819 shares of common stock at an exercise price of $0.0061, subject to adjustments and expires on the five-year anniversary of the Issue Date. As of September 30, 2025, and December 31, 2024, the outstanding principal balance of this note was $375,000. This note is in default and the interest rate from the date of default is the lesser of 24% or the highest amount permitted by law. During the three and nine months ended September 30, 2025, the Holder converted $48,715 and $82,498 of accrued interest into 899,700,800 and 1,331,366,500 shares of common stock at a conversion price of $0.00004 to $0.00008. As of September 30, 2025, and December 31, 2024, the accrued interest is $445,284 and $360,247, respectively. The Company is in discussions with the lender regarding the extension of the maturity date of this note.

**NOTE 8 – DEFERRED LIABILITY**

On September 2, 2020, PCTI entered into an agreement with a third- party. Pursuant to the terms of the agreement, in exchange for $750,000, PCTI agreed to pay the third-party a perpetual three percent (3%) payment of revenues, as defined in the agreement. Payments are due ninety (90) days after each calendar quarter, with the first payment due on or before March 31, 2021, for revenues for the quarter ending December 31, 2020. On February 26, 2021, the agreement was assigned to Ozop and on March 4, 2021, the note was amended, whereby in exchange for 175,000,000 shares of common stock, the royalty percentage was amended to 1.8%. No payments have been made and the Company is in default of the agreement. On November 11, 2022, the third-party and the Company agreed to reduce the liability by $260,000 and add $260,000 to the promissory note issued on November 11, 2022.

EV Insurance Company records premiums received from the issuance of Vehicle Service Contracts ("VSC's") as a deferred liability. The Company will analyze the deferred liability to determine if any amounts can be recorded as income with the balance remaining in deferred liabilities for potential future claims. As of September 30, 2025, and December 31, 2024, the Company has recorded $35,320 and $12,610 as deferred liabilities related to VSC's.

The deferred liability as of September 30, 2025, and December 31, 2024, on the consolidated balance sheets is $525,320 and $502,610, respectively.

**NOTE 9 – RELATED PARTY TRANSACTIONS AND BALANCES**

**Employment Agreement**

On July 10, 2020, pursuant to the PCTI transaction, the Company assumed an employment contract entered into on February 28, 2020, between the Company and Mr. Conway (the "Employment Agreement"). Mr. Conway's compensation as adjusted was $20,000 per month. Effective January 1, 2022, the Company entered into a new employment agreement with Mr. Conway. Pursuant to the agreement, Mr. Conway receives annual compensation of $240,000 from the Company and will also be eligible to receive bonuses and equity grants at the discretion of the BOD. The Company also agreed to compensate Mr. Conway for services provided directly to any of the Company's subsidiaries. Currently, the subsidiaries of Ozop Capital, OES and OED, each compensates Mr. Conway $20,000 per month.

**Management Fees, Sale of Building and Related Party Payables**

For the three and nine months ended September 30, 2025, and 2024, the Company recorded expenses to Mr. Conway of $240,000 and $720,000, respectively. During the three and nine months ended September 30, 2025, the Company sold its building to an entity controlled by Mr. Conway. The sale price was $600,000 and the Company received $100,000 in cash and Mr. Conway forgave $500,000 of related party accrued and unpaid management fees owed. The Company recorded a gain on the sale of the building to a related party of $86,250, which is included in the Statement of Operations for the three and nine months ended September 30, 2025 (see Note 4). After the building was sold to the related party, the Company leased back the building from the same related party in September 2025 for a three-year lease with a monthly lease payment of $5,000 beginning on September 1, 2026, which was accounted for as a sale and leaseback transaction (see Note 13). As of September 30, 2025, and December 31, 2024, the Company owes Mr. Conway $40,000 and $60,000 for unpaid management fees, which is included in related party liabilities on the unaudited consolidated balance sheets presented herein.

**NOTE 10 – COMMITMENTS AND CONTINGENCIES**

***Agreements***

On September 1, 2021, Ozop Capital entered into an advisory agreement (the "RMA Agreement") with Risk Management Advisors, Inc. ("RMA"). Pursuant to the terms of the RMA Agreement, RMA will assist Ozop Capital in analyzing, structuring, and coordinating Ozop Capital's participation in a captive insurance company. RMA will coordinate legal, accounting, tax, actuarial and other services necessary to implement the Company's participation in a captive insurance company, including, but not limited to, the preparation of an actuarial feasibility study, filing of all required regulatory applications, domicile selection, structural selection, and coordination of the preparation of legal documentation. The fee for these services was $100,000. Ozop Capital agreed to pay $50,000 and to issue $50,000 of shares of restricted common stock. The parties agreed to a reduced fee of $48,000 for the years ended December 31, 2024, and 2023, which has been accrued as of September 30, 2025 ($96,000), and December 31, 2024 ($96,000), and is included in accounts payable and accrued expenses on the consolidated balance sheets presented herein. As of September 30, 2025, and December 31, 2024, the Company has recorded 637,755 shares of common stock to be issued for the balance owed, in addition to the $48,000.

On March 4, 2019, the Company entered into a Separation Agreement (the "Separation Agreement") with Salman J. Chaudhry, pursuant to which the Company agreed to pay Mr. Chaudry $227,200 (the "Outstanding Fees") in certain increments as set forth in the Separation Agreement. As of September 30, 2025, and December 31, 2024, the balance owed Mr. Chaudhry is $162,085.

On September 2, 2020, PCTI entered into an Agreement with a third-party. Pursuant to the terms of the agreement, in exchange for $750,000, PCTI agreed to pay the third-party a perpetual three percent (3%) payment of revenues, as defined in the agreement. On February 26, 2021, the agreement was assigned to Ozop and on March 4, 2021, the agreement was amended, whereby in exchange for 175,000,000 shares of common stock, the royalty percentage was amended to 1.8% (see Note 8). As of September 30, 2025, and December 31, 2024, the Company has recorded $243,272, respectively, and is included in accounts payable and accrued expenses on the consolidated balance sheets presented herein.

*Legal matters*

We know of no material, existing or pending legal proceedings against our Company.

We were involved as a plaintiff in a Complaint filed in the **SUPERIOR COURT OF THE STATE OF CALIFORNIA FOR THE COUNTY OF SAN DIEGO NORTH COUNTY (the "Complaint")** on November 14, 2022**.** The Complaint alleges that former employees would place an order from a customer for purchase of product from OZOP with funds the exact source of which is presently unknown. OZOP alleges that next, the customer would sell that product to OZOP's customers at a price marked up from the price for which the customer purchased from OZOP – to the benefit of Defendants and to the detriment of OZOP, their employer at the time. The Complaint further alleges that the former employees falsely represented that the price the customer was obtaining from other suppliers and therefore was willing to pay for OZOP product decreased, which allowed them to use the customer to then sell additional product to OZOP's customers at increasingly larger margins, thus further wrongfully enriching themselves to the detriment of their employer, OZOP. The lawsuit also alleges that the employees were also making false statements to Ozop's customers regarding the financial condition of Ozop and the lack of module inventory.

On April 4, 2024, the Company executed a Settlement Agreement (the "Settlement") with its former employees and Your Home Solutions Corp ("YHS"). YHS and the former employees were all defendants (the "Defendants") in the Complaint. Pursuant to the terms of the Settlement, the Defendants paid the Company $1,125,000 during the year ended December 31, 2024. In exchange, the Company agreed to release all Defendants from the lawsuit and to deliver 11 containers of solar panels. Upon the receipt of the $1,125,000 and the delivery of the 11 containers, and pursuant to the Settlement, the Company recorded sales of $728,640, a credit of $125,000 to legal expense and for the year ended December 31, 2024, recorded a gain on litigation settlement of $271,360.

There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

**NOTE 11– STOCKHOLDERS' EQUITY**

**Common stock**

During the three and nine months ended September 30, 2025, the Company issued an aggregate of 964,363,313 and 2,328,957,493 shares of common stock respectively and received net proceeds of $85,797 and $381,762 after issuance costs of $12,946 and $25,261 respectively.

During the nine months ended September 30, 2025, the Company issued an aggregate of 200,000,000 shares of common stock pursuant to a Service Agreement (including amendments) with a third party and recorded a stock based compensation of $40,000.

During the three and nine months ended September 30, 2025, the Company issued 1,399,700,800 and 1,831,366,500 shares of common stock in payment of convertible notes payable of $50,000 (three and nine months), accrued interest of $48,715 and $82,498 (three and nine months) and fees of $1,500 and 2,250 (three and nine months).

During the three and nine months ended September 30, 2024, the Company issued an aggregate of 53,290,746 and 1,199,808,439 shares of common stock respectively and received net proceeds of $46,771 and $979,048, respectively, after issuance costs of $2,000 and $33,577 respectively.

*<u>Increase in Authorized Shares</u>*

On June 4, 2024, the Board of Directors (the "BOD'') of the Company approved to amend the Company's Articles of Incorporation (the "2024 Amendment") to increase the authorized capital stock of the Company to 9,000,000,000 shares, of which 8,990,000,000 shall be authorized as common shares and 10,000,000 shall be authorized as preferred shares. The Company filed the 2024 Amendment with the State of Nevada on July 22, 2024.

On March 4, 2025, the BOD of the Company approved to amend the Company's Articles of Incorporation (the "2025 Amendment") to increase the authorized capital stock of the Company to 16,000,000,000 shares, of which 15,990,000,000 shall be authorized as common shares and 10,000,000 shall be authorized as preferred shares. The Company filed the 2025 Amendment with the State of Nevada on April 10, 2025.

On May 21, 2025, the BOD of the Company approved to amend the Company's Articles of Incorporation (the "May 2025 Amendment") to increase the authorized capital stock of the Company to 26,000,000,000 shares, of which 25,990,000,000 shall be authorized as common shares and 10,000,000 shall be authorized as preferred shares. The Company filed the May 2025 Amendment with the State of Nevada on July 1, 2025.

As of September 30, 2025, and December 31, 2024, the Company has 25,990,000,000 and 8,990,000,000 shares respectively of $0.001 par value common stock authorized and there are 11,446,345,735 and 7,086,021,742 shares respectively of common stock issued and outstanding.

*<u>Reverse Split</u>*

The BOD of the Corporation also approved a reverse stock split (the "Reverse Split") of the outstanding shares of common stock of the Company at a ratio of 1- for-5,000. The Company has filed the Reverse Split with FINRA. The reverse split has not been effective, and the Company's common stock has not been trading on a Reverse Stock Split-adjusted basis as of the filing date of this quarterly report.

**Preferred stock**

As of September 30, 2025, and December 31, 2024, 10,000,000 shares have been authorized as preferred stock, par value $0.001 (the "Preferred Stock"), which such Preferred Stock shall be issuable in such series, and with such designations, rights and preferences as the Board of Directors may determine from time to time.

**Series C Preferred Stock**

On July 7, 2020, the Company filed an Amended and Restated Certificate of Designation with the State of Nevada of the Company's Series C Preferred Stock. Under the terms of the Amendment to Certificate of Designation of Series C Preferred Stock, 50,000 shares of the Company's preferred remain designated as Series C Preferred Stock. The holders of Series C Preferred Stock have no conversion rights and no dividend rights. For so long as any shares of the Series C Preferred Stock remain issued and outstanding, the Holder thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to sixty-seven (67%) percent of the total vote. As of September 30, 2025, and December 31, 2024, there were 2,500 shares of Series C Preferred Stock issued and outstanding and the shares are held by Mr. Conway.

**Series D Preferred Stock**

On July 7, 2020, the Company filed a Certificate of Designation with the State of Nevada of the Company's Series D Preferred Stock. On July 10, 2020, pursuant to the SPA with PCTI, the Company issued 18,667 shares of Series D preferred Stock to Chis, and on August 28, 2020, pursuant to Mr. Conway's employment agreement, the Company issued 1,333 shares of Series D Preferred Stock to Mr. Conway. On July 13, 2021, the Company purchased 18,667 shares of the Company's Series D Preferred Stock held by Chis.

On July 27, 2021, the Company filed with the Secretary of State of the State of Nevada an Amended and Restated Certificate of Designation of Series D Preferred Stock (the "Series D Amendment"). Under the terms of the Series D Amendment, 4,570 shares of the Company's preferred stock will be designated as Series D Convertible Preferred Stock. The holders of the Series D Convertible Preferred Stock shall not be entitled to receive dividends. Any holder may, at any time convert any number of shares of Series D Convertible Preferred Stock held by such holder into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion, by 1.5 and dividing that number by the number of authorized shares of Series D Convertible Preferred Stock and multiply that result by the number of shares of Series D Convertible Preferred Stock being converted. Except as provided in the Series D Amendment or as otherwise required by law, no holder of the Series D Convertible Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Company for their vote, waiver, release or other action. The Series D Convertible Preferred Stock shall not bear any liquidation rights. On July 28, 2021, the Company closed on a Stock and Warrant Purchase Agreement (the "Series D SPA"). Pursuant to the terms of Series D SPA, an investor in exchange for $13,200,000 purchased one share of Series D Preferred Stock, and a warrant to acquire 3,236 shares of Series D Preferred Stock. As of September 30, 2025, and December 31, 2024, there were 1,334 shares, respectively, of Series D Preferred Stock issued and outstanding and a warrant to purchase 3,236 shares of Series D Preferred Stock are outstanding as of September 30, 2025, and December 31, 2024.

The warrant has a 15- year term and Partial Warrant Lock Up and Leak-Out Period. The Holder may only exercise the Warrant and purchase Warrant Shares as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. Up to 162 (one hundred
 and sixty-two) Warrant Shares, at any time or times on or after five (5) business days from the closing of the Series D SPA ("the
 Initial Exercise Date") subject to up to a maximum number of Warrant Shares that, if converted, would be equal to no more than
 a maximum of 4.99% of the total number of outstanding shares of Common Stock of the Company and no later than on or before the 15<sup>th</sup>
 year anniversary of the Initial Exercise Date ("the Termination Date"); and

ii. The Remainder of the Warrant
 representing up to 3,074 (three thousand and seventy-four) Warrant Shares ("Remaining Warrant Shares") shall be locked
 up for a period of 36 (thirty-six) months from the Initial Exercise Date ("Lock Up Period") and shall become exercisable
 at any time or times from the date that is the 36 (thirty-six) month anniversary of the Initial Exercise Date ("Lock Up Period
 Termination Date") and no later than on or before the Termination Date, as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. During every 1 (one) year
 period, starting on the day that is the Lock Up Period Termination Date, the Holder shall have the right to exercise the Remainder
 of the Warrant up to a maximum number of Remaining Warrant Shares that, if converted, would be equal to no more than a maximum of
 4.99% of the total number of outstanding shares of Common Stock of the Company during such given year ("Leak-Out Period").
 The Leak-Out Period shall come into effect on the day that is the Lock Up Period Termination Date and remain effective on a yearly
 basis, for a period of 10 (ten) years thereafter, after which the Leak-Out Period will automatically terminate and become null and
 void. For clarity purposes the Remainder of the Warrant shall become freely exercisable at any time or times beginning on June 29,
 2034, and until the Termination Date.

**Series E Preferred Stock**

On July 7, 2020, the Company filed a Certificate of Designation with the State of Nevada of the Company's Series E Preferred Stock. Under the terms of the Certificate of Designation of Series E Preferred Stock, 3,000 shares of the Company's preferred stock have been designated as Series E Preferred Stock. The holders of the Series E Convertible Preferred Stock shall not be entitled to receive dividends. No holder of the Series E Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Corporation for their vote, waiver, release or other action, except as may be otherwise expressly required by law. At any time, the Corporation may redeem for cash out of funds legally available therefor, any or all of the outstanding Preferred Stock ("Optional Redemption") at $1,000 (one thousand dollars) per share. The shares of Series E Preferred Stock have not been registered under the Securities Act of 1933 or the laws of any state of the United States and may not be transferred without such registration or an exemption from registration. As of September 30, 2025, and December 31, 2024, there were -0- shares of Series E Preferred Stock issued and outstanding, respectively.

**NOTE 12 – NONCONTROLLING INTEREST**

On August 19, 2021, the Company formed Ozop Capital. The Company initially owned 51% with PJN Holdings, LLC ("PJN") owning 49%. Brian Conway was appointed as the sole officer and director of Ozop Capital and has voting control of Ozop Capital. The Company presents interest held by noncontrolling interest holders within noncontrolling interest in the consolidated financial statements. On September 13, 2022, there was a change in the ownership percentages, as PJN returned 490,000 shares, representing their 49% ownership. As of that date, Ozop Capital is a wholly owned subsidiary of the Company. As of September 30, 2025, and December 31, 2024, the accumulative noncontrolling interest is $784,777, respectively.

**NOTE 13 - OPERATING LEASE RIGHT-OF-USE ASSETS AND OPERATING LEASE LIABILITIES**

On April 14, 2021, the Company entered into a five-year lease which began on June 1, 2021, for approximately 8,100 square feet of office and warehouse space in Carlsbad, California, expiring May 31, 2026. Initial lease payments of $13,148 begin on June 1, 2021, and increase by approximately 2.4% annually thereafter. The interest rate used to determine the present value is our incremental borrowing rate, estimated to be 7.5%, as the interest rate implicit in most of our leases is not readily determinable. During the year ended December 31, 2021, upon adoption of ASC Topic 842, the Company recorded right-of-use assets and lease liabilities of $702,888 for this lease. On February 22, 2023, with an effective date of March 1, 2023, the Company entered into a Sublease for a Single Subleasee Agreement (the "Sublease") with the landlord and a third party for the office and warehouse in Carlsbad California. Pursuant to the Sublease agreement, the third party will be responsible for all of the Company's lease obligations through May 31, 2026, the lease termination date. The Company and the subleasee have agreed to work together regarding any existing Company inventory in the facility.

*<u>Sale-Leaseback Transaction</u>*

In August 2025, the Company sold its building in Warwick, New York to a related party (see Note 4 and Note 9) with the related party obtained full control of the real property and no "continuing involvement" of the Company after the sale. On September 1, 2025, the Company entered into a three-year lease with the same related party to lease back the previously sold building for office space, expiring August 31, 2028. Lease payments of $5,000 begin on September 1, 2026, on a monthly basis. The Company determined that the sale and leaseback transaction qualified as a sale, and the sale and the leaseback were accounted for separately, with the lease being accounted for in accordance with ASC 842. This three-year lease agreement is determined to be an operating lease. The interest rate used to determine the present value is our incremental borrowing rate, estimated to be 7.5%, as the interest rate implicit in most of our leases is not readily determinable. During the three and nine months ended September 30, 2025, the Company recorded right-of-use assets and lease liabilities of $103,107 for this lease.

In adopting Topic 842, the Company has elected the 'package of practical expedients', which permit it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter is not applicable to the Company. In addition, the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12 months or less.

Right-of-use assets are summarized below:

---

| | | |
|:---|:---|:---|
|  | **September 30,<br> 2025** | **December 31,<br> 2024** |
| Office and warehouse lease | $805995 | $702888 |
| Less: Accumulated amortization | (595769) | (476196) |
| Right-of-use assets, net | $210226 | $226692 |

---

Operating lease liabilities are summarized as follows:

---

| | | |
|:---|:---|:---|
|  | **September 30,<br> 2025** | **December 31,<br> 2024** |
| Lease liability | $218937 | $236389 |
| Less current portion | (112130) | (163727) |
| Long term portion | $106807 | $72662 |

---

Maturity of lease liabilities are as follows:

---

| | |
|:---|:---|
|  | Amount |
| For the year ending December 31, 2025 (remaining period) | $44418 |
| For the year ending December 31, 2026 | 94030 |
| For the year ending December 31, 2027 | 60000 |
| For the year ending December 31, 2028 | 40000 |
| Total | $238448 |
| Less: present value discount | (19511) |
| Lease liability | $218937 |

---

For the three and nine months ended September 30, 2025, the Company recorded a debit of $1,317 and credit of $986, respectively, to operating lease expense (after netting off the sublease income). The Company recorded a credit of $979 and $1,256 to operating lease expense (after netting off the sublease income) for the three and nine months ended September 30, 2024.

**NOTE 14 – DISCONTINUED OPERATIONS**

On September 1, 2022, the BOD of the Company authorized the filing of a Chapter 7 proceeding which meets the definition of a discontinued operation. Accordingly, the operating results of PCTI are reported as income from discontinued operations in the unaudited accompanying consolidated financial statements for the three and nine months ended September 30, 2025, and 2024. On October 3, 2022, PCTI filed a Voluntary Petition for Non- Individuals Filing for Bankruptcy. On November 30, 2022, the Trustee filed a Notice of Abandonment of Estate Property, as it is over encumbered by the secured creditors. No objections were filed, and as such the inventory and equipment is now considered abandoned to the secured creditors to do with what they wish. In March 2023, the Trustee declared this a no-asset case and closed the bankruptcy.

The results of operations of this component, for all periods, are separately reported as "discontinued operations". A reconciliation of the major classes of line items constituting the income (loss) from discontinued operations, net of income taxes as is presented in the Consolidated Statements of Operations for the three and nine months ended September 30, 2025, and 2024 are summarized below:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three months ended <br> September 30, | Three months ended <br> September 30, | Nine months ended <br> September 30, | Nine months ended <br> September 30, |
|  | 2025 | 2024 | 2025 | 2024 |
| Revenues | $- | $- | $- | $3573 |
| Cost of goods sold | - | - | - | - |
| Gross profit |  |  |  | 3573 |
| Operating expenses |  |  |  |  |
| Interest expense | - | - | - | - |
| Income from discontinued operations | $- | $- | $- | $3573 |

---

There areno assets as of September 30, 2025, and December 31, 2024, as the secured lender has taken possession. Liabilities of discontinued operations are separately reported as of September 30, 2025, and December 31, 2024. All liabilities are classified as current. The following tables present the reconciliation of carrying amounts of the major classes of liabilities of the Company classified as discontinued operations in the consolidated balance sheets at September 30, 2025, and December 31, 2024:

**Current liabilities**

---

| | | |
|:---|:---|:---|
|  | September 30,<br> 2025 | December 31,<br> 2024 |
| Accounts payable and accrued liabilities | $445565 | $445565 |
| Current portion of notes payable | 589246 | 589246 |
| Total current liabilities of discontinued operations | $1034811 | $1034811 |

---

On May 16, 2022, Huntington National Bank ("Huntington") filed a Complaint for Confession of Judgment ("COJ") against Catherine Chis ("Chis"). Chis was the former CEO of PCTI and a Guarantor on Huntington's Letter of Credit financing ("LOC") and a Term Loan ("Term Loan"). The Chis COJ for the LOC was for $352,415 and accrues per diem interest of $63.65, and the Chis COJ for the Term Loan was for $141,415 and accrues per diem interest of $28.60. On June 24, 2022, Huntington filed a COJ against Power Conversion Technologies, Inc ("PCTI"). The PCTI COJ for the LOC was for $354,774 and accrues per diem interest of $63.65 and the PCTI COJ for the LOC was for $142,473 and accrues per diem interest of $28.60. On July 20, 2022, Huntington assigned the PCTI judgment against PCTI to Meraki Advisors, LLC. ("Meraki"). The Company's understanding is Meraki is a Pennsylvania limited liability company, controlled by Chis.

Included in the Current portion of notes payable are the principal balances of Huntington's LOC of $344,166 and Term Loan of $134,681. Accrued interest and fees on the LOC and Term Loan debt $54,256 is included in accounts payable and accrued liabilities.

**NOTE 15 - INCOME TAXES**

The Company provides for income taxes under ASC 740, Accounting for Income Taxes. ASC 740 requires the use of an asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. ASC 740 requires the reduction of deferred tax assets by a valuation allowance if, based on the weight of available evidence, it is more likely- than not that some or all of the deferred tax assets will not be realized.

In assessing the need for a valuation allowance, management must determine that there will be sufficient taxable income to allow for the realization of deferred tax assets. Based upon the historical and anticipated future income, management has determined that the deferred tax assets do not meet the more-likely-than-not threshold for realizability. Accordingly, there is a full valuation allowance provided against the Company's deferred tax assets as of September 30, 2025, and December 31, 2024.

As of September 30, 2025, the Company has approximately $33,941,000 net operating loss carryforwards available to reduce future taxable income. As of September 30, 2025, and December 31, 2024, the Company has no material unrecognized tax benefits which would favourably affect the effective income tax rate in future periods and does not believe that there will be any significant increases or decreases of unrecognized tax benefits within the next twelve months. No interest or penalties relating to income tax matters have been imposed on the Company during the three and nine months ended September 30, 2025, and 2024, and no provision for interest and penalties is deemed necessary as of September 30, 2025, and December 31, 2024.

**NOTE 16 – SUBSEQUENT EVENTS**

On October 2, 2025, the holder of the February 9, 2021 note converted $50,000 of the note into 500,000,000 shares of common stock.

On October 14, 2025, the Holder of the promissory note dated August 24, 2020, converted $23,095 of accrued interest into 596,122,600 shares of common stock at a conversion price of $0.00004.

On October 27, 2025, the Company sold GHS 151,857,500 shares of common stock for proceeds of $10,406 net of offering costs.

The Company has evaluated subsequent events through the date the financial statements were issued. The Company has determined that there are no other such events that warrant disclosure or recognition in the financial statements, except as stated herein.

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.**

*The following is management's discussion and analysis of certain significant factors that have affected our financial position and operating results during the periods included in the accompanying unaudited consolidated financial statements, as well as information relating to the plans of our current management. This report includes forward-looking statements. Generally, the words "believes," "anticipates," "may," "will," "should," "expect," "intend," "estimate," "continue," and similar expressions or the negative thereof or comparable terminology are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, including the matters set forth in this report or other reports or documents we file with the Securities and Exchange Commission from time to time, which could cause actual results or outcomes to differ materially from those projected. Undue reliance should not be placed on these forward-looking statements which speak only as of the date hereof. We undertake no obligation to update these forward-looking statements.*

While our financial statements are presented on the basis that we are a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business over a reasonable length of time, our auditors have raised a substantial doubt about our ability to continue as a going concern.

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States ("GAAP"). These accounting principles require us to make certain estimates, judgments, and assumptions. We believe that the estimates, judgments, and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments, and assumptions are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our financial statements would be affected to the extent there are material differences between these estimates.

The following discussion should be read in conjunction with our unaudited consolidated financial statements and the related notes that appear elsewhere in this Quarterly Report on Form 10-Q.

**THE COMPANY**

Ozop Energy Solutions, Inc. (the "Company," "we," "us" or "our") was originally incorporated as Newmarkt Corp. on July 17, 2015, under the laws of the State of Nevada.

On October 29, 2020, the Company formed a new wholly owned subsidiary, Ozop Surgical Name Change Subsidiary, Inc., a Nevada corporation ("Merger Sub"). The Merger Sub was formed under the Nevada Revised Statutes for the sole purpose and effect of changing the Company's name to "Ozop Energy Solutions, Inc." That same day the Company entered into an Agreement and Plan of Merger (the "Merger Agreement") with the Merger Sub and filed Articles of Merger (the "Articles of Merger") with the Nevada Secretary of State, merging the Merger Sub into the Company, which were stamped effective as of November 3, 2020. As permitted by the Section 92.A.180 of the Nevada Revised Statutes, the sole purpose and effect of the filing of Articles of Merger was to change the name of the Company from Ozop Surgical Corp to "Ozop Energy Solutions, Inc."

On December 11, 2020, the Company formed Ozop Energy Systems, Inc. ("OES"), a Nevada corporation and a wholly owned subsidiary of the Company. OES was formed to be a manufacturer and distributor of renewable energy products.

On August 19, 2021, the Company formed Ozop Capital Partners, Inc. ("Ozop Capital"), a Delaware corporation and a wholly owned subsidiary of the Company. Brian Conway was appointed as the sole officer and director of Ozop Capital and has voting control of Ozop Capital.

On October 29, 2021, EV Insurance Company, Inc. ("EVCO") was formed as a captive insurance company in the State of Delaware. EVCO is a wholly owned subsidiary of Ozop Capital. On January 7, 2022, EVCO filed with New Castle County, Delaware DBA OZOP Plus.

On February 25, 2022, the Company formed Ozop Engineering and Design, Inc. ("OED") a Nevada corporation, as a wholly owned subsidiary of the Company. OED was formed to become a premier engineering and lighting control design firm. OED offers product and design support for lighting and solar projects with a focus on fast lead times and technical support. OED and our partners are able to offer the resources needed for lighting, solar and electrical design projects. OED will provide customers systems to coordinate the understanding of electrical usage with the relationship between lighting design and lighting controls, by developing more efficient ecofriendly designs. We work with architects, engineers, facility managers, electrical contractors and engineers.

On June 11, 2024, the Company formed Automated Room Controls, Inc. ("ARC") a Nevada corporation, as a wholly owned subsidiary of the Company. ARC was created to address a significant need in the lighting controls industry. We believe that easy deployment and creative applications can transform lighting controls into essential tools for enhancing the utility and ambiance of any space. The Company's mission is to deliver cutting-edge technology that simplifies complex control needs, ensuring seamless integration and exceptional performance.

OES operates in the renewable, electric vehicle ("EV"), energy storage and energy resiliency sectors. We are engaged in multiple business lines that include project development as well as equipment distribution.

*<u>Equipment Distributor:</u>* In April 2021, the Company signed a five-year lease (beginning June 1, 2021) of approximately 8,100 SF in California, for office and warehouse space to support the sales and distribution of our west coast operations. On February 22, 2023, with an effective date of March 1, 2023, the Company entered into a Sublease for a Single Subleasee Agreement (the "Sublease") with the landlord and a third party for the office and warehouse in Carlsbad California. Pursuant to the Sublease agreement, the third party will be responsible for all of the Company's lease obligations through May 31, 2026, the lease termination date. The Company and the subleasee have agreed to work together regarding any existing Company inventory in the facility.

*<u>Modular Energy Distribution System:</u>* The **NeoVolt<sup>™</sup>** System comprises the design engineering, installation, and operational methodologies as well as the financial arbitrage of how we produce, capture and distribute electrical energy for the EV markets. Our **NeoVolt<sup>TM</sup> System** offers (1) charging locations that can be installed with reduced delays, restricted areas or load limits and (2) EV charger electricity that is produced from renewable sources claiming little to no carbon footprint.

The Company has developed a business plan for NeoVolt™, a scalable battery storage solution that aims to relieve the stress on existing grid infrastructure by providing distributed energy storage. With the first stage of engineered technical drawings completed, we are advancing to stage two and preparing to construct the initial prototype or proof of concept (PoC). NeoVolt™ is designed with advanced features, including automatic adoption of connected devices and dynamic load balancing through a master-slave configuration. These capabilities enable NeoVolt™ to seamlessly integrate with and manage energy flows across multiple devices. Furthermore, the PoC is contingent upon recent advancements in EV charging and discharging standardizations, including on-board inverters and bi-directional capabilities, to ensure compatibility and efficiency in both residential and commercial applications.

OED specializes in lighting commissioning services. On September 27, 2024, OED signed an agreement with Leviton Manufacturing Co, Inc., to serve as a field service technician for their advanced lighting control systems.

Ozop Plus markets vehicle service contracts (VSC's") for electric vehicles (EV's) that offer consumers to be able to purchase additional months and miles above the manufacturer's warranty and to also bring added value to EV owners by utilizing our partnerships and strengths in the energy market to offer unique and innovative services. Among EV owners' concerns are the EV battery repair and replacement costs, range anxiety, environmental responsibilities, roadside assistance, and the accelerated wear on additional components that EV vehicles experience. Management believes that the Ozop Plus marketed VSC's will give "peace of mind" to the EV buyer. On October 23, 2024, Ozop Capital Partners, Inc. entered into an agreement with Empire Auto Protect ("Empire"). Under the agreement, Empire will white label Royal Administration's Fully Charged VSC, to be marketed as Empire Plus. OZOP Plus will be ceded the battery premium portion of all of the Empire Plus VSC's contracted.

ARC has developed products to be an advanced lighting controls system, intricately engineered to integrate sophisticated wired and wireless technologies. At its core, it employs a hybrid network topology that facilitates both resilient wired connections and flexible wireless communications, making it suitable for complex infrastructural environments. The system is equipped with an array of sensors and control nodes, enabling precise light management and energy usage monitoring. With support for protocols such as DALI and Zigbee, alongside the capability for seamless integration with IoT platforms, ARC offers a comprehensive solution for intricate lighting networks. This system is designed not just for control and efficiency, but also for adaptability to diverse architectural and electrical layouts, embodying a technical solution for advanced, energy-conscious lighting management.

***Discontinued Operations***

On September 1, 2022, the BOD of the Company authorized the filing of a Chapter 7 proceedings which meets the definition of a discontinued operation. Accordingly, the operating results of PCTI are reported as income from discontinued operations in the accompanying unaudited consolidated financial statements for the three and nine months ended September 30, 2025, and 2024.

**Results of Operations for the three and nine months ended September 30, 2025, and 2024:**

*Revenue*

For the three and nine months ended September 30, 2025, the Company generated revenue of $142,840 and $248,828 compared to $74,286 and $1,267,980 for the three and nine months ended September 30, 2024. Revenues from Ozop Energy Systems, Inc. ("OES") and Automated Room Controls, Inc ("ARC") are classified as sourced and distributed products. Revenues from Ozop Engineering and Design ("OED") are classified as design and installation. Sales are summarized as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three months ended <br> September 30, | Three months ended <br> September 30, | Nine months ended <br> September 30, | Nine months ended <br> September 30, |
|  | 2025 | 2024 | 2025 | 2024 |
| Sourced and distributed products | $75986 | $51104 | $98464 | $1005878 |
| Design and installation | 66854 | 23182 | 150364 | 262102 |
| Total | $142840 | $74286 | $248828 | $1267980 |

---

Sales for OES (included in sourced and distributed products) for the nine months ended September 30, 2024, included $728,640, pursuant to the YHS Settlement. Excluding this, sales of sourced and distributed products were significantly lower for the nine months ended September 30, 2025, compared to the nine months ended September 30, 2024. The Company believes the lower revenues were due to higher interest rates affecting homeowners' ability and desire for residential rooftop solar installations as well as competitors lowering their selling prices to try to capture a part of the lower demand. These factors also resulted in our customers having excess inventory on hand, and our decision to not currently place additional orders for solar products. Sales of sourced and distributed products for the three and nine months ended September 30, 2025, also includes $75,986 and $86,368 of revenues from ARC. Design and installation revenues increased for three months ended September 30, 2025, compared to the three months ended September 30, 2024, as a result of new customers, and decreased for the nine months ended September 30, 2025, compared to the nine months ended September 30, 2024, as the nine months ended September 30, 2024, included $162,000 for a one-time large installation job.

*Cost of sales and Gross profit*

For the three and nine months ended September 30, 2025, the Company recognized $91,575 and $170,211, respectively, of cost of sales, compared to $50,863 and $989,955, respectively, for the three and nine months ended September 30, 2024.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three months ended <br> September 30, | Three months ended <br> September 30, | Nine months ended <br> September 30, | Nine months ended <br> September 30, |
|  | 2025 | 2024 | 2025 | 2024 |
| Sourced and distributed products | $51194 | $43440 | $70223 | $916627 |
| Design and installation | 40381 | 7423 | 99988 | 73328 |
| Total | $91575 | $50863 | $170211 | $989955 |

---

The Company recognized a gross margin on solar products (OES) of -0- and 11.8% for the three and nine months ended September 30, 2025, compared to 15% and 8.9% for the three and nine months ended September 30, 2024. ARC products had a gross margin of 32.6% and 31.1%, respectively, for the three and nine months ended September 30, 2025.

Design and installation cost of sales is comprised of OED's labor costs for each job. The Company recognized a gross margin on design and installation of 39.6% and 33.5% for the three and nine months ended September 30, 2025, compared to 68% and 72% for the three and nine months ended September 30, 2024. The decrease in gross margin percentage is primarily a result of a new customer in the current three and nine month periods who compensates the Company based on hourly rate for actual hours worked as compared to a higher daily rate the Company received from other customers on the prior year periods.

*Operating expenses*

Total operating expenses for the three and nine months ended September 30, 2025, were $635,840 and $2,419,484, respectively, compared to $963,460 and $2,740,395, respectively, for the three and nine months ended September 30, 2024. The operating expenses were comprised of:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended <br> September 30,<br> 2025 | Three Months Ended <br> September 30, <br> 2024 | Nine Months Ended <br> September 30, <br> 2025 | Nine Months Ended <br> September 30, <br> 2024 |
| Management fees, related parties | $240000 | $240000 | $720000 | $720000 |
| Salaries, taxes, and benefits | 63505 | 220094 | 439009 | 618271 |
| Stock compensation consultants |  |  | 40000 |  |
| Travel expenses | 2431 | 13950 | 36688 | 77307 |
| Professional and consulting fees | 170125 | 219144 | 627400 | 596381 |
| Advertising and marketing | 5787 | 6805 | 31155 | 35354 |
| Rent and office expenses | 20545 | 18969 | 46750 | 131395 |
| Research and development costs |  | 87778 | 44872 | 115262 |
| Insurance | 46828 | 43536 | 158845 | 151526 |
| General and administrative, other | 86619 | 113184 | 274765 | 294899 |
| Total operating expenses | $635840 | $963460 | $2419484 | $2740395 |

---

Effective January 1, 2022, the Company entered into an employment agreement with Mr. Conway. Pursuant to the agreement, Mr. Conway receives annual compensation of $240,000 from the Company and will also be eligible to receive bonuses and equity grants at the discretion of the BOD. The Company also agreed to compensate Mr. Conway for services provided directly to any of the Company's subsidiaries. Currently, the subsidiaries of Ozop Capital, OES and OED, each compensates Mr. Conway $20,000 per month.

Salaries, taxes, and benefits decreased for the three and nine months ended September 30, 2025, compared to the three and nine months ended September 30, 2024. As of September 30, 2025, Ozop Energy Systems had 1 employee with an annual salary of $78,000 and focused on general and administrative functions. The solar distribution of this vertical is being managed by our financial consultant and the Company's CEO. OED has two part-time employees paid on an hourly basis. OED has allocated $40,381 and $99,988 of salaries to cost of sales for the three and nine months ended September 30, 2025, and $7,423 and $73,328 of salaries to cost of sales for the three and nine months ended September 30, 2024. ARC is currently being managed by the Company's CEO and financial consultant. Ozop Capital Partners had one employee with annual compensation of $125,000 (terminated in July 2024), and hired a new employee on September 3, 2024, with an annual salary of $144,000. The Company allocates salaries and related expenses to the appropriate subsidiary for where their services are being performed. The expenses per subsidiary included in operating expenses for the three and nine months ended September 30, 2025, and 2024, are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended <br> September 30, <br> 2025 | Three Months Ended <br> September 30,<br> 2024 | Nine Months Ended <br> September 30, <br> 2025 | Nine Months Ended <br> September 30,<br> 2024 |
| Ozop Energy Systems | $22606 | $51787 | $111627 | $162325 |
| Ozop Engineering and Design | 2662 | 81679 | 70977 | 301326 |
| Automated Room Controls | 6198 | 58917 | 157760 | 58917 |
| Ozop Capital Partners/EV Insurance Company | 32039 | 27711 | 98645 | 95703 |
| Total | $63505 | $220094 | $439009 | $618271 |

---

Travel expenses decreased for the three and nine months ended September 30, 2025, compared to the three and nine months ended September 30, 2024, as the Company had lower travel expenses related to Systems and OED.

Professional and consulting fees decreased for the three months ended September 30, 2025, compared to the three months ended September 30, 2024, and increased for the nine months ended September 30, 2025, compared to the nine months ended September 30, 2024. During the nine months ended September 30, 2024, the Company received $125,000 pursuant to the YHS settlement, that was credited to legal fees for the nine months ended September 30, 2024.

Rent and office expense (including storage, supplies, utilities, and internet costs) increased for the three months ended September 30, 2025, compared to the three months ended September 30, 2024, because of the Company selling their building and entering into a new lease agreement effective September 1, 2025. Rent and office expense decreased for the nine months ended September 30, 2025, compared to the nine months ended September 30, 2024, because of $71,208 expenses incurred by OES for storage fees in the nine months ended September 30, 2024 (no such storage fees in the nine months ended September 30, 2025).

Research and development costs decreased for the three and nine months ended September 30, 2025, compared to the three and nine months ended September 30, 2024, due to the development and testing of the ARC products in 2024.

*Other (Income) Expenses*

Other expense, net, for the three and nine months ended September 30, 2025, was $1,211,600 and $3,218,477, respectively, compared to $1,153,046 and $2,349,872, respectively, for the three and nine months ended September 30, 2024, and were as follows.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three months ended <br> September 30, | Three months ended <br> September 30, | Nine months ended <br> September 30, | Nine months ended <br> September 30, |
|  | 2025 | 2024 | 2025 | 2024 |
| Interest expense | $1138538 | $1056866 | $2627912 | $3170633 |
| Loss (gain) on change in fair value of derivatives | 159312 | 96180 | 676815 | (549401) |
| Gain on sale of building to a related party | (86250) |  | (86250) |  |
| Gain on litigation settlement | - | - | - | (271360) |
| Total other (income) expense, net | $1211600 | $1153046 | $3218477 | $2349872 |

---

The increase in interest expense for the three months ended September 30, 2025, was as a result of new amortization related to the debt discount for the convertible notes issued in the Exchange Agreement, partially offset by certain note discounts that were completed in 2024. The decrease in interest expense for the nine months ended September 30, 2025, is primarily a result of the amortization period of certain note discounts that were completed in 2024. For the three and nine months ended September 30, 2025, the Company recognized a loss of $159,312 and $676,815, respectively, on the change in the fair value of derivatives compared to a loss of $96,180 and a gain of $549,401, respectively, for the three and nine months ended September 30, 2024. Additionally for the three and nine months ended September 30, 2025, the Company recognized a gain of $86,250 for the sale of a building to a related party and a gain of $271,360 for the nine months ended September 30, 2024, on the settlement with YHS.

*Net loss*

Net loss attributable to the Company for the three and nine months ended September 30, 2025, was $1,796,175 and $5,559,344, respectively, compared to $2,093,083 and $4,808,669, respectively, for the three and nine months ended September 30, 2024.

**Liquidity and Capital Resources**

The accompanying unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of September 30, 2025, the Company had an accumulated deficit of $230,427,985 and a working capital deficit of $36,273,834. As of September 30, 2025, the Company was in default of $17,725,000 plus accrued interest on debt instruments due to non-payment upon maturity dates. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for one year from the date of the issuance of these financial statements. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

Currently, our current capital and our other existing resources will not be sufficient to provide the working capital needed for our current business, and, additional capital will be required to meet our debt obligations, and to further expand our business. We may be unable to obtain the additional capital required. If we are unable to generate capital or raise additional funds when required, it will have a negative impact on our business development and financial results. These conditions raise substantial doubt about our ability to continue as a going concern as well as our recurring losses from operations, deficit in equity, and the need to raise additional capital to fund operations. This "going concern" could impair our ability to finance our operations through the sale of debt or equity securities. Management's plans in regard to these factors are discussed in Note 2 to the unaudited consolidated financial statements filed herein.

For the nine months ended September 30, 2025, we primarily funded our business operations with the existing cash on hand as of January 1, 2025, cash received from collection of accounts receivable, $573,000 from the issuances of convertible notes payable, $381,762 received from sales of common stock, $100,000 received in the sale of building to a related party, and $150,000 from the issuance of a note payable.

As of September 30, 2025, we had cash of $341,164 as compared to $797,139 as of December 31, 2024. As of September 30, 2025, we had current liabilities of $36,844,296, compared to current assets of $570,462, which resulted in a working capital deficit of $36,273,834. The current liabilities are comprised of accounts payable and accrued expenses, related party liabilities, convertible debt, derivative liabilities, lease obligations, deferred liability, notes payable, and liabilities of discontinued operations.

Operating Activities

For the nine months ended September 30, 2025, net cash used in operating activities was $1,657,247 compared to $1,059,327 for the nine months ended September 30, 2024.

For the nine months ended September 30, 2025, our net cash used in operating activities was primarily attributable to the net loss of $5,559,344, the gain on the sale of building to a related party of $86,250, adjusted by the loss on the change in fair value of derivatives of $676,815, interest expense of $340,522, stock based compensation of $40,000, and amortization and depreciation of $156,685. Net changes of $2,774,325 in operating assets and liabilities reduced the cash used in operating activities.

For the nine months ended September 30, 2024, our net cash used in operating activities was primarily attributable to the net loss of $4,808,669, the gain on the change in fair value of derivatives of $549,401, adjusted by non-cash items of interest expense of $998,970, and amortization and depreciation of $160,988. Net changes of $3,142,358 in operating assets and liabilities reduced the cash used in operating activities.

Investing Activities

For the nine months ended September 30, 2025, the net cash provided by investing activities was $96,510, resulting from the sale of the building to a related party, less the purchase of office and computer equipment. For the nine months ended September 30, 2024, the net cash used in investing activities was $11,114 primarily due to purchase of office and computer equipment.

Financing Activities

For the nine months ended September 30, 2025, the net cash provided by financing activities was $1,104,762 of which $573,000 was net proceeds received from issuance of convertible notes, $381,762 from the sales of common stock to GHS, net of issuance costs, and $150,000 from the issuance of a note payable. For the nine months ended September 30, 2024, the net cash provided by financing activities was $979,048, net of issuance costs, from the sales of common stock to GHS.

***Critical Accounting Policies and Estimates***

The Company's unaudited consolidated financial statements are prepared in accordance with GAAP in the United States. The preparation of its consolidated financial statements and related disclosures requires it to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, costs and expenses, and the disclosure of contingent assets and liabilities in the Company's unaudited consolidated financial statements. The Company bases its estimates on historical experience, known trends and events and various other factors that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company evaluates its estimates and assumptions on an ongoing basis. Actual results may differ from these estimates under different assumptions or conditions.

Our senior management has reviewed the critical accounting policies and estimates with our Board of Directors. For a description of the Company's critical accounting policies and estimates, refer to "Part II—Item 7—Management's Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies and Estimates" in our most recent Annual Report on Form 10-K for the year ended December 31, 2024, which was filed with the SEC on April 15, 2025. Critical accounting policies are those that are most important to the portrayal of our financial condition, results of operations and cash flows and require management's most difficult, subjective and complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. If actual results were to differ significantly from estimates made, the reported results could be materially affected. There were no significant changes to our critical accounting policies and estimates during the three and nine months ended September 30, 2025.

**OFF BALANCE SHEET ARRANGEMENTS**

We have no off-balance sheet arrangements, including arrangements that would affect our liquidity, capital resources, market risk support and credit risk support or other benefits.

**Item 3. Quantitative and Qualitative Disclosures about Market Risk.**

Not Applicable.

**Item 4. Controls and Procedures.**

***Disclosure Controls and Procedures***

We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934 (the "Exchange Act"), that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures as of September 30, 2025. Based on the evaluation of these disclosure controls and procedures, and in light of the material weaknesses found in our internal controls over financial reporting, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective for the reasons discussed below.

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company's annual or interim financial statements will not be prevented or detected on a timely basis. In its assessment of the effectiveness of internal control over financial reporting as of September 30, 2025, the Company determined that there were control deficiencies that constituted material weaknesses, as described below.

&nbsp;&nbsp;&nbsp;&nbsp;1. We do not have an Audit
 Committee – While not being legally obligated to have an audit committee, it is the management's view that such a committee,
 including a financial expert member, is an utmost important entity level control over the Company's financial statement. Currently
 the Board of Directors acts in the capacity of the Audit Committee, and does not include a member that is considered to be independent
 of management to provide the necessary oversight over management's activities.

&nbsp;&nbsp;&nbsp;&nbsp;2. We did not maintain appropriate
 cash controls – As of September 30, 2025, the Company has not maintained sufficient internal controls over financial reporting
 for cash, including failure to segregate cash handling and accounting functions, and did not require dual signatures on the Company's
 bank accounts.

Accordingly, the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the company's internal controls.

Our management, including our Chief Executive Officer and our Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected.

***Changes in Internal Controls over Financial Reporting***

There has been no change in our internal control over financial reporting during the three and nine months ended September 30, 2025, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

**PART II. OTHER INFORMATION**

**Item 1. LEGAL PROCEEDINGS**

There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

**Item 1A. RISK FACTORS**

Not applicable for smaller reporting companies.

**Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

On August 7, 2025, the Company issued 355,675,100 shares of common stock in payment of accrued interest of $27,704 and fees of $750.

On August 20, 2025, the Company issued 500,000,000 shares of common stock in a partial payment of $50,000 of a convertible note payable.

On September 9, 2025, the Company issued 544,025,700 shares of common stock in payment of accrued interest of $21,011 and fees of $750.

**Item 3. DEFAULTS UPON SENIOR SECURITIES**

**None**

**Item 4. MINE SAFETY DISCLOSURE**

Not applicable.

**Item 5. OTHER INFORMATION**

&nbsp;&nbsp;&nbsp;&nbsp;(a) None.

(b) During the quarter ended
 September 30, 2025, there have not been any material changes to the procedures by which security holders may recommend nominees to
 the Board of Directors.

**Item 6. EXHIBITS**

The following documents are filed as part of this report:

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 2.1 | [Share Exchange Agreement dated April 5, 2018 by and among Newmarkt Corp., the shareholders of Ozop Surgical, Inc., Ozop Surgical, Inc. and Denis Razvodovskij (Incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed on April 19, 2018).](https://www.sec.gov/Archives/edgar/data/1679817/000155479518000101/nwkt0418form8kexh2_1.htm) |
| 2.2 | [Stock Purchase Agreement dated June 26, 2020, by and among Ozop Surgical Corp., Power Conversion Technologies, Inc. and Catherine Chis (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on June 29, 2020).](https://www.sec.gov/Archives/edgar/data/1679817/000149315220012101/ex10-1.htm) |
| 2.3 | [Merger Agreement and Plan of Merger between Ozop Surgical Corp. and Ozop Surgical Name Change Subsidiary, Inc. (Incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed on November 13, 2020).](https://www.sec.gov/Archives/edgar/data/1679817/000149315220021213/ex2-1.htm) |
| 3.1 | [Articles of Incorporation (Incorporated by reference to our General Form for Registration of Securities on Form S-1 filed on August 1, 2016)](https://www.sec.gov/Archives/edgar/data/1679817/000167981716000001/ex_03-1.htm) |
| 3.2 | [Bylaws (Incorporated by reference to our General Form for Registration of Securities on Form S-1 filed on August 1, 2016)](https://www.sec.gov/Archives/edgar/data/1679817/000167981716000001/ex_03-2.htm) |
| 3.3 | [Certificate of Amendment of Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on May 8, 2018 (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on May 14, 2018).](https://www.sec.gov/Archives/edgar/data/1679817/000155479518000123/nwkt0511form8kexh3_1.htm) |
| 3.4 | [Certificate of Designations for Series B Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on April 2, 2019).](https://www.sec.gov/Archives/edgar/data/1679817/000155479519000091/ozsc0401form8kexh3_1.htm) |
| 3.5 | [Amended and Restated Bylaws of Ozop Surgical Corp. adopted on May 22, 2019. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on May 22, 2019).](https://www.sec.gov/Archives/edgar/data/1679817/000155479519000165/ozsc0522form8kexh3_2.htm) |
| 3.6 | [Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on July 25, 2019. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on July 30, 2019).](https://www.sec.gov/Archives/edgar/data/1679817/000155479519000220/ozsc0729form8kexh3_1.htm) |
| 3.7 | [Certificate of Designation of Series C Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on September 24, 2019).](https://www.sec.gov/Archives/edgar/data/1679817/000155479519000336/ozsc0923form8kexh3_1.htm) |
| 3.8 | [Certificate of Withdrawal of Series B Preferred Stock. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on September 24, 2019).](https://www.sec.gov/Archives/edgar/data/1679817/000155479519000336/ozsc0923form8kexh3_2.htm) |

---

---

| | |
|:---|:---|
| 3.9 | [Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on October 29, 2019. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on October 31, 2019).](https://www.sec.gov/Archives/edgar/data/1679817/000155479519000364/ozsc1028form8kexh3_1.htm) |
| 3.10 | [Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on December 30, 2020, (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on December 31, 2019).](https://www.sec.gov/Archives/edgar/data/1679817/000155479519000418/ozsc1230form8kexh3_1.htm) |
| 3.11 | [Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on January 21, 2020. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on February 7, 2020).](https://www.sec.gov/Archives/edgar/data/1679817/000155479520000035/ozsc0206form8kexh3_1.htm) |
| 3.12 | [Amended and Restated Certificate of Designation of Series C Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on February 5, 2020).](https://www.sec.gov/Archives/edgar/data/1679817/000155479520000031/ozsc0205form8kexh3_1.htm) |
| 3.13 | [Amendment to Certificate of Designation of Series C Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on July 10, 2020).](https://www.sec.gov/Archives/edgar/data/1679817/000149315220013006/ex3-1.htm) |
| 3.14 | [Certificate of Designation of Series D Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on July 10, 2020).](https://www.sec.gov/Archives/edgar/data/1679817/000149315220013006/ex3-2.htm) |
| 3.15 | [Certificate of Designation of Series E Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.3 of the Current Report on Form 8-K filed on July 10, 2020).](https://www.sec.gov/Archives/edgar/data/1679817/000149315220013006/ex3-3.htm) |
| 3.16 | [Articles of Incorporation of Ozop Surgical Name Change Subsidiary, Inc. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on November 13, 2020).](https://www.sec.gov/Archives/edgar/data/1679817/000149315220021213/ex3-1.htm) |
| 3.17 | [Articles of Merger between Ozop Surgical Corp. and Ozop Surgical Name Change Subsidiary, Inc. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on November 13, 2020).](https://www.sec.gov/Archives/edgar/data/1679817/000149315220021213/ex3-2.htm) |
| 3.18 | [Amended and Restated Certificate of Designation Series D Preferred Stock dated July 27, 2021 (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on August 2, 2021).](https://www.sec.gov/Archives/edgar/data/1679817/000149315221018324/ex3-1.htm) |
| 3.19 | [Advisory agreement between Ozop Capital and RMA dated September 1, 2021 (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on September 2, 2021)](https://www.sec.gov/Archives/edgar/data/1679817/000149315221021822/ex10-1.htm) |
| 10.1 | [Binding Letter of Intent dated February 28, 2020, by and between Ozop Surgical Corp. and Power Conversion Technologies, Inc, and Catherine Chis, (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on February 28, 2020).](https://www.sec.gov/Archives/edgar/data/1679817/000155479520000053/ozsc0227form8kexh10_1.htm) |
| 10.2+ | [Employment Agreement dated February 28, 2020, by and between Ozop Surgical Corp. and Brian Conway, (Incorporated by reference to Exhibit 10.3 of the Current Report on Form 8-K filed on February 28, 2020).](https://www.sec.gov/Archives/edgar/data/1679817/000155479520000053/ozsc0227form8kexh10_3.htm) |
| 31.1\* | [Certification of Chief Executive Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31-1.htm) |
| 31.2\* | [Certification of Chief Financial Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31-2.htm) |
| 32.1\* | [Certification of Chief Executive Officer and the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C. 63](ex32-1.htm) |

---

---

| | |
|:---|:---|
| 101.INS\* | Inline XBRL Instance Document |
| 101.SCH\* | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL\* | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF\* | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB\* | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE\* | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

\* Filed herewith.

+ Management contract or compensatory plan or arrangement.

**SIGNATURES**

**Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.**

Dated: November 19, 2025

---

| |
|:---|
| ***/s/ Brian P Conway*** |
| Brian P. Conway |
| Chief Executive Officer |
| (principal executive officer) |
| (principal financial and accounting officer) |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION**

I, Brian P. Conway, Chief Executive Officer of OZOP ENERGY SOLUTIONS, INC. (the "registrant"), certify that:

1. I have reviewed this quarterly
 report on Form 10-Q of the registrant for the period ended September 30, 2025;

2. Based on my knowledge,
 this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
 made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
 report;

3. Based on my knowledge,
 the financial statements, and other financial information included in this report, fairly present in all material respects the financial
 condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's
 other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined
 in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f)
 and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;a. Designed such disclosure
 controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
 information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities,
 particularly during the period in which this report is being prepared;

b. Designed such internal
 control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
 to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
 external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness
 of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness
 of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report
 any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent
 fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is
 reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's
 other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting,
 to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the
 equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;a. All significant deficiencies
 and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
 affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not
 material, that involves management or other employees who have a significant role in the registrant's internal control over
 financial reporting.

Date: November 19, 2025

---

| |
|:---|
| ***/s/ Brian P. Conway*** |
| Brian P Conway |
| Chief Executive Officer |
| (principal executive officer) |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION**

I, Brian P. Conway, Interim Chief Financial Officer of OZOP ENERGY SOLUTIONS, INC. (the "registrant"), certify that:

1. I have reviewed this quarterly
 report on Form 10-Q of the registrant for the period ended September 30, 2025;

2. Based on my knowledge,
 this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
 made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
 report;

3. Based on my knowledge,
 the financial statements, and other financial information included in this report, fairly present in all material respects the financial
 condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's
 other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined
 in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f)
 and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;a. Designed such disclosure
 controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
 information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities,
 particularly during the period in which this report is being prepared;

b. Designed such internal
 control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
 to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
 external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness
 of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness
 of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report
 any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent
 fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is
 reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's
 other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting,
 to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the
 equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;a. All significant deficiencies
 and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
 affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not
 material, that involves management or other employees who have a significant role in the registrant's internal control over
 financial reporting.

Date: November 19, 2025

---

| |
|:---|
| ***/s/ Brian P Conway*** |
| Brian P Conway |
| Interim Chief Financial Officer |
| (principal financial and accounting officer) |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

Each of the undersigned hereby certifies, in his capacity as an officer of OZOP ENERGY SOLUTIONS, INC. (the "Company"), for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

(1) The Company's Quarterly
 Report on Form 10-Q for the period ended September 30, 2025, (the "Report") fully complies with the requirements of Section
 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained
 in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 19, 2025

---

| |
|:---|
| ***/s/ Brian P Conway*** |
| Brian P. Conway |
| Chief Executive Officer |
| (principal executive officer) |
| (principal financial and accounting officer) |

---